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Magnetic resonance spectroscopy (MRS) was established, upon independent 
discovery of nuclear magnetic resonance (NMR) phenomenon, by Bloch and Purcell in 
1946 (Bloch, 1946, Bloch et al., 1946b, Bloch et al., 1946a, Purcell et al., 1946). They 
observed resonance absorption and emission of spins placed in a static, strong external 
magnetic field and described time evolution of the nuclear magnetization - in relation to 
the external magnetic fields and to the relaxation times (T1 and T2). The method was 
initially of interest only to physicists for measuring the gyromagnetic ratios (γ) of 
different elements in the periodic table. However, four years later, the chemical shift 
phenomenon came to light, in which influence of the chemical environment of a 
nucleus, on its resonance frequency, was realized (Dickinson, 1950, Proctor and Yu, 
1950). Following the discovery of the spin echo (Hahn, 1950) and of spin–spin coupling 
(Ramsey and Purcell, 1952), NMR spectroscopy gradually developed into the most 
versatile technique for non-invasive probing of molecular structure, as well as molecular 
motions and reaction dynamics. The diagnostic value of (proton) NMR in medical 
applications was apprehended first by Damadian (Damadian, 1971), reporting the 
different magnetic relaxation times of malignant tumors from those of normal tissues. 
With the advent of linear magnetic field gradients (Lauterbur, 1973, Mansfield and 
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Grannell, 1973), new opportunities were presented to derive spatial density information 
of nuclei inside an object that paved the way for technical developments of modern 
localized spectroscopy. 
Complementary to the insights provided by structural and functional magnetic 
resonance imaging (MRI) methods, magnetic resonance spectroscopy (MRS) offers 
unique access to major tissue metabolites concentration in vivo. This particularly applies 
to proton MRS (1H MRS) studies of the central nervous system, where spectral 
recordings cover metabolites involved in energy metabolism, membrane turnover, glial 
proliferation, and neuroaxonal integrity. Accessible key metabolites are N-
acetylaspartate (NAA), a neuroaxonal marker linked to neuronal viability and function, 
creatine (Cr) and phosphocreatine (PCr) as important energy metabolites and 
constituents of all cells, choline-containing compounds (Cho) representing formation 
and degradation products of cell membranes such as glycerophosphocholine (GPC) and 
phosphocholine (PCh) which are predominantly present in oligodendrocytes, and myo-
inositol (Ins) as a marker for astrocytes. Alterations of these compounds have been 
demonstrated to be indicative for a variety of pathological processes and they are 
monitored during the course of disease progression. Other metabolites such as lactate 
(Lac), alanine (Ala), N-acetylaspartylglutamate (NAAG), aspartate (Asp), γ-aminobutyric 
acid (GABA), and taurine (Tau) can be used for a more detailed analysis of affected brain 
tissue. Specific marker compounds could be identified, through MRS, for glial cells 
(oligodendrocytes, astrocytes) and neurons (including their axons). As a consequence, 
technical developments of suitable localization sequences were rapidly followed by 
applications to human brain under both physiologic and pathologic conditions. STEAM 
(STimulated Echo Aquisition Mode)(Frahm et al., 1989a) and PRESS (Point RESolved 
Spectroscopy)(Bottomley, 1987) localization techniques are among those used for 
volume selection and have gained widespread acceptance. Pertinent studies cover a 
broad range of disorders, including focal brain lesions as well as neurometabolic and 
neurodegenerative diseases.  Questions not only address diagnostic issues but expand to 
the (early) monitoring of therapeutic success. 
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So far, a variety of localized spectroscopy studies were carried out on animals 
including mice (Schwarcz et al., 2003), rats (Gyngell et al., 1991a, Gyngell et al., 1991b, 
Gyngell et al., 1992, Fujimori et al., 1998, Michaelis et al., 1999, Wick et al., 1999, 
Liebetanz et al., 2003) and tree shrews (Czeh et al., 2001, Michaelis et al., 2001, van der 
Hart et al., 2002, Czeh et al., 2005). However, previous animal MRS studies were limited, 
in terms of spatial resolution and/or sensitivity, because of the use of relatively low field 
strength of 2.35 T. Applications of MRS at high field is faced with several important 
hurdles that need to be surmounted, some of which involve signal loss due to J-
modulation of spin-coupled resonances, T2 relaxation, chemical shift displacement error, 
increased magnetic susceptibility, residual eddy currents, and magnetic field instability 
(Frahm et al., 1989b, Howe et al., 1993, Di Costanzo et al., 2003). The recent availability 
of MR systems operating at higher magnetic fields, as well as the subsequent technical 
and methodological advances, have brought about substantial improvements in 
sensitivity and in spatial, temporal and spectral resolution, allowing reliable 
quantification of a much larger number of metabolites from smaller brain regions in 
reasonable measuring time (Gruetter et al., 1998).  
Several years ago in vivo 1H NMR spectroscopy at 9.4 T has first been 
demonstrated on the rat brain (Pfeuffer et al., 1999, Tkád et al., 1999) and later on the 
mouse brain (Tkád et al., 2004). However, there are several limitations in their method: 
(i) Very short echo time of 2 ms was selected for the acquisition of spectra. This may 
cause considerable contribution of the signal of unspecific macromolecules, which have 
very short T2 relaxation times. This hampers the quality of the baseline of the spectra 
and, thus, increases the risk of under- and over-estimation in quantifying the 
concentration of metabolites. (ii) A surface coil was used, not only for signal reception 
but also for radiofrequency (RF) excitation. This may pose a risk of inhomogeneous 
excitation profile (B1), which has an influence on the quality of the localization of the 
volume-of-interest (VOI), in particular, when it is localized at distances far away from the 
surface coil. (iii) The instability of B0 caused a noticeable frequency drift in the course of 
measurement, which required a correction for each spectrum, prior to averaging. (iv) An 
additional step was required in correction of spectra, possibly because application of 
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very strong spoiler gradients, forced by the very short echo time, caused substantially 
uncompensated eddy currents. The spoiler gradients must be applied for spoiling the 
unwanted echo. (v) Seven RF pulses were used for the suppression of the water signal. 
This increases the risk of unwanted echo formation. In addition, magnetization exchange 
with water protons, as a result of long water suppression scheme, can attenuate methyl 
signal of creatine. (vi) Only orthogonal volumes-of-interest were used, which limit the 
localization for specific brain regions.  
In the current work, centering on STEAM, the method of choice for single-voxel 
localization, these limitations will be overcome respectively: (i) optimal echo time (TE) of 
10 ms will be employed, which minimizes the unspecific macromolecule signals while 
reducing substantial T2 relaxation losses and J-modulation of coupled spins. (ii) Use of 
quadrature volume resonator will provide more homogeneous excitation profile. This 
will enable a sufficiently reliable localization to obtain adequate signals - even from the 
brain regions remote from the surface coil. (iii) state-of-the-art magnet and shim coils 
will ensure stability in B0. (iv) 12 cm inner diameter self-shielded gradient coil insert 
(Resonance Research Inc, Billerica, MA, USA) will provide sophisticated eddy current 
compensation, while being capable of supplying up to 400 mTm−1 in 80 μs rise time. (v) 
Use of only three RF pulses in water suppression scheme, in analogy to what is proposed 
by Ernst et al (Ernst and Hennig, 1995), will minimize the risk of unwanted echo 
formation. (vi) Use of oblique volume-of-interest will facilitate localization for specific 
brain regions. 
With these improvements, the primary objective of the research presented in 
this thesis is to implement and optimize a STEAM localization technique on a 9.4 T MRI 
system, to perform state-of-the-art single-voxel 1H MRS in vivo, taking full advantage of 
the gain in SNR and chemical shift dispersion at higher field strengths. Further, these 
modifications will require, (i) systematic investigation of bandwidths and inter-pulse 
delays of water suppression pulses for in vitro condition as well as for mouse brain in 
vivo, (ii) systematic investigation of the relative detectability of strongly coupled 
metabolite resonances at 9.4 T compared to lower field strength. 
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The second objective of this project is concerned with the absolute quantification 
of regional neurochemical profiles in healthy mouse brain in vivo, to test and validate 
the developed spectroscopic method and the quantification technique. Development of 
in vivo techniques for characterizing the brains of mice is of great importance because a 
growing number of mutant mice are being generated for a better understanding of 
pathological mechanisms, which underlie human brain disorders. The non-invasiveness 
of 1H MRS enables repeated assessment of longitudinal treatment on behaving mice, 
which represents a model of chronic human disorders. In this regard, high 
reproducibility of the method is essential to unveil subtle variation of neurochemical 
profile in the longitudinal investigations of physiological or pathophysiological processes. 
So far, there are only a few laboratories that can perform proton MRS studies of the 
mouse brain in vivo, probably because it has specific requirements (Lei et al., 2010, Öz et 
al., 2010, Oberg et al., 2008). Immobilization of mice is challenging because anesthetics 
may alter cerebral metabolism. The small size of the sample is another challenge 
because signal must be collected from much smaller subregions of the mouse brain, 
compared to that of human. In the previous work, using the smallest volume-of-interest 
(VOI) for mouse brain in vivo, metabolite concentrations were determined for only four 
different regions (Tkád et al., 2004). Further, scyllo-Ins has not yet been described for 
mice in vivo, despite its detectable concentration in human brain (Michaelis et al., 
1993a, Seaquist and Gruetter, 1998). Only one study has investigated the intra- and 
inter-individual variability in mouse brain in vivo (Öz et al., 2010).  
Thus, to achieve the second objective of this project, (i) experimental setup, e.g., 
the selection of the coils, the method of anesthesia, the maintenance of body 
temperature, and the fixation of the head of the mouse, will be developed for repeated 
MRS of the same mouse and for examining the reproducibility of the method, (ii) VOI 
localization technique for MRS will be optimized for 10 different brain regions of 
anesthetized mice, (iii) T1 and T2 relaxation times from different brain regions of 
anesthetized mice will be measured for a correct quantification of metabolite 
concentrations, (iv) intra- and inter-individual reproducibility of MR spectroscopic 
acquisition protocol and of quantified data analysis will be assessed, (v) absolute 
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concentrations of 16 different brain metabolites, including scyllo-Ins from anesthetized 
mice, will be quantified and presented with necessary statistical values. Once 
established, the new high-field MRS protocol will be ready to be exploited for future 
studies on metabolic and cellular characterization of the brain in a large number of 
existing animal models. This will enable us to assess the metabolic profiles in genetically 
modified mice, including models of human brain in basic neuroscience studies. In fact, 
the experimental setup, which has been developed and established in the present work, 
recently provided a new insight into cerebral metabolism (Michaelis et al., 2009, 
Boretius et al., 2013). 
In this thesis, after the physical basis of 1H MRS is described (Chapter 2), 
optimization of STEAM sequence parameters as well as attributed modules is presented 
in Chapter 3. Firstly, the issues of water suppression, outer-volume suppression and 
automatic localized shimming techniques are addressed because they are stringent 
requirements for short-TE 1H NMR spectroscopy that needs to be complied with. 
Further, relative detectability of strongly coupled metabolites at low-field (2.35 T) 
strength is compared to that at high-field (9.4 T) to further clarify the relative merits of 
field strengths. In Chapter 4, the experimental development for MRS of the brain of 
anesthetized mice is described. The acquisition of metabolite model spectra and the 
generation of the basis set, as a priori knowledge, are essential for the employed 
quantification technique, which enables a user-independent analysis. Special emphasis is 
placed on the characterization of potential impacts of signal loss, associated with T1 and 
T2 relaxation, as well as of cerebrospinal fluid (CSF) contribution on metabolite 
quantification. Finally, the reliability and reproducibility of the in vivo metabolite 










Physical Basics of Magnetic Resonance 
2.1 Spin Magnetization 
Particular nuclei hold a property that is termed spin. Any atomic nucleus with an 
odd number of neutrons and/or protons, possesses angular momentum L and a 
magnetic dipole moment, µ which they are related according to: 
 𝝁 = 𝛾𝑳 =  𝛾ℏ𝑰 (2.1) 
   
Where 𝛾 is called gyromagnetic ratio, an intrinsic constant the particular nucleus 
that is determined by the ratio of the nuclear charge to its mass, I is the nuclear spin 
quantum number, and ℏ is Planck’s constant over 2π. The magnetic parameters of some 
selected nuclei commonly used in clinical MRS are enumerated in Table 2.1. 
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 Table 2.1 Basic properties of some popular nuclei in in vivo NMR 
 
 
In the presence of a static magnetic field (𝐵0), there are  2𝐼 + 1  possible spin 
states with integer steps ranging from +𝐼 to −𝐼, which is known as the Zeeman splitting. 
As an example, 1H nucleus with I = 
1
2







corresponding to the parallel or anti-parallel alignment of nuclear magnetic moments 
with respect to the external magnetic field. It should be noted that larger magnetic fields 
give rise to greater alignment of the spins. 
 
Figure 2.1: Zeeman splitting of nuclear spin states. In the absence of an external magnetic field (B0 = 0), 
the two energy eigenstates of the spin 1/2 particle are degenerated. For B0  0, Zeeman splitting is 
observed. Reproduced from (Pohmann, 2011) 
  



























                                       Reproduced from (Storey, 2005) 
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). In this case, energy difference between two different energy eigenstates of 
±1/2𝛾ℏ𝐵0 will be (see Fig. 2.1) 
 ∆𝐸 = 𝛾ℏ𝐵0  (2.2) 
 
Therefore, the Larmor frequency, ω0, which is the angular frequency at which the 
angular momentum precesses about the magnetic field axis, can be expressed as:  
 𝜔0 = 𝛾𝐵0 (2.3) 
 
The population difference between the spin states, under thermal equilibrium 









𝑘𝐵𝑇  (2.4) 
 
Where ∆𝐸 is known as the energy difference between adjacent Zeeman levels, 
kB  is the Boltzmann's constant  kB = 1.38 ∙ 10
−23  𝐽𝐾−1  and 𝑇 is the (absolute) 
temperature.  
 
Given that the difference between energy state for protons at room temperature 
will be small for relatively small 𝐵0, 𝛾ℏ𝐵0 𝑘𝐵𝑇 ≪ 1, it is reasonable to make a first-









NMR signal intensity is dependent on the excess in population of nuclear spin in 
the lower energy state which is extremely small (e.g.,  𝑁𝐿𝑜𝑤 − 𝑁𝐻𝑖𝑔𝑕 𝑁𝐿𝑜𝑤 ≈
𝛾ℏ𝐵0
𝑘𝐵𝑇
~10−5 for 1 Tesla). This is translated into an intrinsically low sensitivity of magnetic 
resonance techniques. The equilibrium magnetization 𝑀0 is given by: 
 𝑴𝟎 =  𝑁𝐿𝑜𝑤 − 𝑁𝐻𝑖𝑔𝑕 𝝁 (2.6) 
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The net magnetization in a system of nuclei with a spin 𝐼 in an external field 𝐵0 





2ℏ2𝐼 𝐼 + 1 
3𝑘𝐵𝑇
𝐵0 (2.7) 
Where 𝑁𝑠  is the total number of spins in the sample. Hence, higher static 
magnetic fields give rise to increased equilibrium magnetization, which is, in fact, an 
enhancement of the MR signal and sensitivity. 
  
 




2.2 Chemical shift 
The underlying concept of NMR spectroscopy is based on the chemical shift 
phenomenon. Nuclei in different molecular environments precess at slightly different 
frequencies. This is a consequence of the fact that the rotation of the electron cloud 
around the nucleus induces diamagnetic shielding that opposes the external field 𝐵0. 
Thus, the effective magnetic field experienced by the nucleus can be expressed as: 
 𝐵 = 𝐵0 1 − 𝜎  (2.8) 
 
where 𝜎 is a shielding (or screening) constant. Chemical shift is normally 
expressed in the dimensionless unit of parts per million (ppm) instead of in Hz, which 




× 106 (2.9) 
 
where 𝜔𝑖  is the resonance frequency of the given nuclei and 𝜔𝑟  is an arbitrary 
chosen reference frequency. TMS [Tetramethylsilane, Si(CH3)4] and DSS (sodium 2,2-
dimethyl-2-silapentane-5-sulphonate) are commonly used substances as internal 
chemical shift reference  𝛿𝑝𝑝𝑚 = 0 , in in vitro 
1H and 13C spectroscopy. In in vivo 
situation, methyl singlet of N-acetyl aspartate (NAA) with a chemical shift value of 2.01 
ppm is often used as an in vivo standard in 1H NMR spectrum. 
  
 






H NMR spectrum acquired from a sample consisting of the fat and water. Reproduced from 
(de Graaf, 2007) 
 
 
As an example, protons in the fat tissue experience stronger shielding than those 
in water. Therefore their resonance frequency is slightly lower, leading to approximately 
3.5 ppm shift of the spectral line to the right in the spectrum as shown in Figure 2.2. To 
this end, different metabolites can be identified on account of the fact that chemical 
shift values for given nuclei are different in each chemical environment. 
  
 




2.3 spin-spin coupling 
Along with the chemical shift, the resonance frequency of a nucleus can be 
altered through another molecular interaction known as spin-spin coupling or J-coupling. 
This phenomenon results in the fine structure of the NMR resonances in the forms of 
splittings (or multiplets). The spin of one nucleus perturbs the energy levels of 
neighboring magnetic nuclei, through polarization of the bonding electrons within a 
molecule. The effective magnetic field sensed by one nucleus is dependent on the spin 
state of a vicinal coupled nucleus. 
The frequency difference between the multiplet peaks reflects the J-coupling 
constant. This constant, which is measured in Hz, implies intensity of coupling. In 
contrast to the chemical shift, J- coupling constant is independent of static magnetic 
field strength. The spin-spin coupling can be found for both heteronuclear (e.g., 1H–13C) 
and homonuclear (e.g., 1H–1H) interactions. Accordingly, the coupling constants 
observed for directly coupled spins (heteronuclear) are in the range of 100–200 Hz, 
while those from the indirect couple spins are in the range of 1–15 Hz [refrence from 
H3]. The number of lines that appeared in the multiplet is 2𝑛𝐼+1 where 𝑛 is the number 
of equivalent coupled nuclei and 𝐼 their nuclear spin. 
Considering the magnitude of J-coupling constants, with respect to the value of 
chemical shift distinction observed between the spins, coupling can be categorized into 
weak (J ≪ δ) or strong (J ≈ δ). For weak coupling, spectral analysis can be treated by 
first-order approximation; however, quantum-mechanical treatment is required for a 
strong coupling regime. 
 By convention, in the terminology used to describe spin systems, each individual 
spin will be assigned to letters, where alphabetical proximity of the letters indicating the 
coupling strength. e.g. AB is a strongly coupled spin system whereas AX is a weakly 
coupled one. The same hold true for systems with more than two spins, such as AX3 
(e.g. lactate) and AMNPQ (e.g. glutamate). 
 




Figure 2.3: Molecular structure and 
1
H spectrum of lactate. The experimental Localized 
1
H MRS 1D STEAM 
spectrum for a 50 mM Lac phantom (27 μL volume) at 9.4 T (TR/TE = 15000/10 ms, 32 scans) shows a 
doublet due to the CH3 group at 1.33 ppm, and a quartet from the CH group at 4.10 ppm. The “sinc 
wiggles” seen around the base of the peak are originated from truncation of data before FID has decayed 
to noise level, whereas the T2 values of metabolites in vitro are likely to be longer than those in in vivo 
condition. 
 
1H spectrum of lactate, as shown in Figure 2.3, is a typical example for a “weakly 
coupled system” and can be used to explain spin coupling. The resonance caused by 
methyl protons in the lactate molecule (X in the AX3 system) produces a doublet 
centered at 1.33 ppm due to interactions with the methine proton (A), which holds two 
possible states of up or down. 
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On the other hand, the methine (CH) resonance at 4.10 ppm is split into a 
quartet because of the coupling with three equivalent protons of the methyl group (CH3) 
since, for each of which, four states are assumed. 
 
 
2.4 Single-Voxel MR Spectroscopy 
The simplest setup for NMR experiment can be established by applying an 
excitation RF pulse followed by detecting the induced oscillating current, arising from 
the rotating magnetic moments in an RF coil. The resultant signal, often called free 
induction decay (FID), is an exponentially damped sine wave. Fourier transform of the 
FID produces the NMR spectrum, providing the information on constituent nuclei of the 
sample. 
In in vivo 1H NMR spectroscopy, it is essential that information be obtained only 
from certain regions of the tissue. The advent and availability of static field gradients led 
to the development of numerous methods for in vivo localized MR spectroscopy.  
STEAM (STimulated Echo Aquisition Mode (Frahm et al., 1987, Frahm et al., 
1989a) spectroscopy and PRESS (Point RESolved Spectroscopy, (Bottomley, 1987)) 
localization technique, also known as double spin-echo, are among those used for 
volume selection and have gained widespread acceptance. 
Both methods provide single-shot capabilities to acquire spectroscopic data from 
the VOI and are particularly advantageous over multi-shot techniques like image 
selected in vivo spectroscopy (ISIS), which is inherently based on multiple excitation 
followed by phase cycling scheme (Ordidge et al., 1986). This makes ISIS vulnerable to 
motion and contaminated with unwanted signal outside the VOI (Frahm and Hänicke, 
2000). An additional advantage of single-shot is the ability to perform localized 
shimming, water suppression, and RF pulse gain adjustments on the desired VOI. 
Both techniques employ three consecutive frequency-selective RF pulses in the 
presence of mutually orthogonal magnetic field gradients to achieve three-dimensional 
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localization (volume selection). In this way, the desired VOI can be defined by the 
intersection of three perpendicular slices. 
While STEAM uses three 90° slice-selective excitation pulses, in PRESS the second 
and the third ones are replaced by two 180° slice-selective refocusing RF pulses. In 
comparison with STEAM, application of 180° pulses increases RF power requirements 
and results in a higher amount of power deposition. This problem becomes even more 
pronounced at higher field strength. Moreover, inferior voxel definition is assumed due 
to sensitivity to pulse imperfections (B1 inhomogeneity, non-ideal pulse shapes, off-
resonance effects, phase-shift errors)(Hore, 1983). This necessitates the use of pairs of 
spoiler gradients around the refocusing pulses to eliminate inadvertently generated 
transverse magnetization (Keevil, 2006), making the minimum attainable TE times longer 
and, consequently, resulting in more signal losses through T2 mechanisms compared to 
STEAM (Gillies and Morse, 2005). In addition, pulse imperfections give rise to a far more 
complicated evolution behaviour, which was investigated analytically, simulated 
numerically, and discussed in detail in previous publications (Trabesinger et al., 2005, 
Lange et al., 2006). 
Figure 2.4 shows the STEAM pulse sequence, which will be used in this work. 
Application of three 90° degree RF pulses initiates three FIDs (following each pulse), four 
normal spin-echoes, and one special signal generated after the third pulse, which is 
referred to as a ‘stimulated echo’ (Hahn, 1950). Spoiler gradients are required to 
preserve the desired signal, while eliminating the unwanted ones. 
  
 




Figure 2.4: Schematic diagrams of the RF pulse and magnetic field gradients sequences commonly applied 
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The amplitude of the resultant signal in STEAM is theoretically half of that in its 
spin-echo counterparts PRESS, as a result of isotropic spin distribution (de Graaf, 2007). 
However, to preclude aforementioned limitations, STEAM was considered the 
method of choice in this thesis, since it offers advantages for observation of very short T2 









Localized proton magnetic resonance 
spectroscopy at high magnetic field 
strength 
3.1 Introduction 
3.1.1 Localized shimming 
Placing the object inside the magnet will disturb the static magnetic field 
homogeneity. In localized magnetic resonance spectroscopy, this results in a variation of 
the Larmor frequency inside the volume of interest and thus, leads to a poor 
localization. In addition, magnetic field inhomogeneities will cause a widening of the 
resonance peaks of metabolites, a distortion of spectral lineshapes and thus, a reduction 
in the signal-to-noise ratio (SNR), which potentially reduces the accuracy of the 
metabolite quantitation. Another adverse outcome is spectral overlap, which has a 
profound effect on quantification accuracy of metabolite concentration (Stanley et al., 
1995, Gruber et al., 2003, Macrì et al., 2004, Bartha, 2007). Moreover, macroscopic field 
heterogeneity causes deterioration in water (or fat) suppression quality, particularly 
when selective saturation method must be applied. Therefore, the improvement in 
magnetic field homogeneity is vital for spectral resolution and hence, for reliable and 
reproducible quantification of metabolites. 
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Fast Automated Shimming Technique by Mapping Along Projections (FASTMAP) 
(Gruetter and Boesch, 1992, Gruetter, 1993, Gruetter and Tkád, 2000) is a widely used 
localized automated shimming approach, which rapidly acquires information from six 
linear field map projections to adjust all first- (X, Y, Z) and second-order (Z2, ZX, ZY, X2-
Y2, 2XY) shim coils (see Fig. 3 .1)(Faber and Webb, 2007, Koch et al., 2009). In other 
words, the required correction current changes for the second-order spherical harmonic 
shim fields are calculated through decomposition of magnetic field inhomogeneities into 
first- and second-order spherical harmonic functions. 
 
Figure 3 .1: Six linear field-map projections diagonally acquired along rectangular columns (sticks) defined 
by the intersection of the two orthogonal slices through the selected shim voxel. (Reproduced from 
ParaVision manual, Advanced Users Manual D-4: Fastmap)  
  
 




3.1.2 Water Suppression 
In the brain tissues, the concentrations of brain metabolites are much lower than 
the concentration of water. Whereas the concentration of water protons is roughly 
80M, cerebral metabolite levels are on the order of mM. Consequently, the localized 1H 
MR spectrum is dominated by the signal from water. Hence, water suppression 
techniques are pivotal to observe the metabolite resonances in in vivo 1H spectroscopy. 
Figure 3.2 shows a perfect example of a water-suppressed localized proton NMR 
spectrum of aqueous solution of GABA, using STEAM spectroscopy in comparison to that 
acquired without application of water suppression. 
 
Figure 3.2: Localized proton NMR spectrum of an aqueous solution of 200 mM GABA obtained without (a) 
and with (b) applying CHESS water suppression module. Axial RARE image (inset) illustrates the location of 
the VOI in the center of spherical phantom. The water signal intensity is reduced drastically. Accordingly, 
resolved proton resonances of GABA are clearly visible in the spectrum. 
 
Incomplete water suppression will result in baseline distortion and, 
consequently, degrades the quantification certainty. A desirable water suppression 
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method should reduce the water amplitude well below the metabolite amplitude, 
without overflowing the digitizer, for a limited dynamic range of analog-to-digital 
converters (ADCs) of the RF receiver channel. Moreover, this eliminates baseline 
distortions linked to residual water and prevents spurious signals such as sidebands 
aroused from system instabilities. However, a consistent amount of residual water can 
be readily exploited for phase and eddy current correction (Klose, 1990) or 
quantification of metabolite.  
Several attempts have been made and many techniques have been suggested for 
more efficient suppression of water signal, mainly including relaxation based techniques, 
binomial based, frequency selective refocusing or excitation and frequency selective 
saturation. 
 WEFT (water eliminated Fourier transform) was initially developed on the basis 
of the difference in longitudinal T1 Relaxation and employed in high resolution NMR 
(Patt and Sykes, 1972). This is similar to inversion recovery sequence, which consists of 
180° selective inversion pulse followed by a delay to main sequence. After 180° pulse, a 
spoiler gradient is applied when water longitudinal magnetization recovered to its zero 
value, in order to dephase water signal prior to the localization pulse sequence. 
Therefore, metabolite magnetization is partially preserved during delay to excitation 
pulse. This is the reason why it is also considered to be an inversion nulling method. The 
result can be further enhanced in in vivo application for several T1, using multiple 
inversion nulling with optimized delay (Berkelbach van der Sprenkel et al., 1992, Duijn et 
al., 1992). An alternate water suppression method for taking advantage of T1 differences 
by using 90◦–t–180◦–t–90◦ sequence was reported by Becker, in which t is considered as 
an inter-pulse delay (Becker et al., 1969, Shoup et al., 1972). Driven equilibrium Fourier 
transform (DEFT) has been introduced in the past as a method of signal enhancement 
for acquisitions with short repetition times in pulsed 13C magnetic resonance 
spectroscopy. The appropriate selection of t brings about nulling of the longitudinal 
component of the water magnetization after inversion pulse whereas metabolite 
magnetization recovered before excitation pulse. However, in several respects, the use 
of T1 based methods is disadvantageous for the suppression of water resonance in vivo. 
In particular, relatively minor differences of T1 relaxation time between water and 
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metabolite in the in vivo situation, lead to attenuation of metabolite as well, 
consequently resulting in unreliable metabolite quantification. 
Additionally, beside the T1-selective method pointed out above, another 
category of water suppression techniques were established on binomial pulses, which 
originally have proven to be useful to achieve selective excitation for water suppression 
applications at high resolution NMR spectroscopy (Hore, 1983). Longitudinal 
magnetization of solvent is nullified in excitation profile of frequency-selective pulse 
trains, for example, DANTE RF pulses (delays alternating with nutation for tailored 
excitation) employs a series of rectangular (hard) pulses with short duration (Morris and 
Freeman, 1978). Albeit, it was recognized that periodical frequency response of these 
pulses may induce phase and amplitude modulations over the spectrum. Potential 
limitations can be stated for these approaches, namely, high power deposition due to 
using hard pulses but less than low power saturation of the water signal technique. 
Another weakness is the difficulties in utilizing in short echo time single shot localization 
sequences like STEAM or PRESS. 
WATERGATE (water-suppression by gradient-tailored excitation) method is a way 
of achieving enhancement of the frequency profile generated by tailored selective 
excitation pulses, which has been presented by Piotto and Sklenar et al. (Piotto et al., 
1992, Sklenar et al., 1993). In this approach, performance of binomial pulse in pulse train 
has been noticeably improved by numerical optimization of sub-pulses property such as 
inter-pulse intervals, pulse lengths and phases. However, Gradient field distortion, 
originating entirely from eddy currents, is considered as a potential problem for the 
methods employing pulse field gradients (Guéron and Plateau, 2007). 
Along with all of the aforementioned methods, presaturation of the water signal 
in in vivo MRS can be accomplished by chemical shift selective (CHESS) (Haase et al., 
1985) saturation, which is one of the most robust and popular approaches for water 
suppression. Figure 3.3 shows a schematic diagram of CHESS water suppression, which 
was employed in this thesis. Three successive frequency-selective excitation rf pulse and 
associated spoiler gradients are instantly applied, prior to localization pulse sequence. 
Various versions of CHESS have been established to result in further improvement in 
suppression performance. By employing more than one CHESS cycle (Frahm et al., 1990) 
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and optimization of corresponding Gaussian pulses flip angle (Webb et al., 1994, Ernst 
and Hennig, 1995), suppression factor of more >1000 can be typically achieved over a 
range of T1 relaxation times.  
 
 
Figure 3.3: Schematic illustration of the chemical-shift-selective (CHESS) water suppression sequence used 
for localized proton spectroscopy of mouse brain at high magnetic field (9.4 T). Sequence comprised of 
three successive Gaussian pulses of duration 7.83 ms, giving a saturation bandwidth of 350 Hz together 
with associated spoiler gradients. The interleaved outer volume suppression blocks are not shown, but are 
applied after each CHESS element. τ is the inter-pulse delay. 
 
DRYSTEAM (drastic reduction of water signals in spectroscopy with the 
stimulated echo acquisition mode) additionally utilizes CHESS pulses during mixing time 
(TM) of STEAM sequence when the magnetization vector is longitudinal (Moonen and 
Vanzijl, 1990). However, this approach was not pursued in the present work, since 
mixing time was kept short to avoid signal attenuation caused by subject motion or as a 
result of diffusion in the period between the two B0 magnetic field gradients in TE 
(Frahm et al., 1990).  
Likewise, to reduce the impact of longitudinal relaxation decay during TM, which 
might introduce complications on spectral quantification, other variants of CHESS 
method have also been proposed by applying more than three CHESS cycles. In a variant 
known as WET (water suppression enhanced through T1 effects), Ogg et al. attained T1- 
and B1-insensitive suppression by utilizing four Gaussian pulse with numerically 
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optimized flip angle (Ogg et al., 1994). Another suppression method to further 
circumvent the disadvantages of sensitivity to B1 and T1 was proposed (Tkád et al., 1999). 
VAPOR (variable pulse power and optimized relaxation) applies seven asymmetrical and 
numerically optimized RF pulses. It is important to bear in mind that the increased 
number of CHESS elements may increase the risk of occurrence of unwanted echoes, 
due to using a number of RF and gradient pulses. Moreover, magnetization exchange 
with water protons, as a result of long water suppression scheme, can attenuate methyl 
signal of creatine. Therefore, the suppression scheme in the current work only employed 
three CHESS RF pulses, based primarily on the properties of Ernst et al (Ernst and 
Hennig, 1995). 
One of the primary goals of this study was to find out the proper water 
suppression parameters (e.g., RF shape, band width, inter-pulse delay, and spoiler 
gradient strength) at 9.4 T in such a way that any important information on metabolite 
resonances in the typical spectral range (up to 4.2 PPM) will not be lost. To achieve this 
goal, the influence of each parameter on the applied water suppression performance 
was systematically investigated for optimization. The effectiveness of suppression was 
verified in both phantom and for mouse brain in vivo. 
3.1.2 Outer Volume Suppression (OVS) 
 
In short, echo time localized spectroscopy, particularly in cortical regions, intense 
lipid signal predominantly stemming from skull with short spin-spin relaxation time, can 
obscure metabolites resonances such as lactate and alanine, owing to their spectral 
overlap. On the other hand, concerning the localization performance quality of 
sequence, one should keep in mind that employing a larger crusher gradient may 
introduce eddy current artifact to spectrum, while insufficient spoiling may raise the 
chance for occurrence of unwanted coherences from outside of volume of interest, like 
those arising from regions with inferior field homogeneity (i.e. mouth or sinuses). In this 
work, the effects of different strategies for mitigating possible signal contamination, 
originating from outside of the selected volume, were investigated.   
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3.1.4 The relative detectability of strongly coupled 
metabolite resonances in proton MR spectra at low- and 
high-field strength  
  
Most major cerebral metabolites are detectable in short-echo time proton MRS at both 
low (e.g., 2.35–4.7 T) and high field strengths (≥ 7.0 T). High fields certainly offer 
advantages in terms of SNR and, therefore, allow for the use of reasonably small 
volumes-of-interest (VOI). In addition, the precision of metabolite quantification and 
detectability of weakly represented metabolites has been reported to increase 
substantially at 7T, relative to 4T (Tkád et al., 2009). On the other hand, a potential 
merging of multiplet signal pattern may offer a better relative detectability of its 
respective resonance at low magnetic fields. The purpose of this work was to evaluate 
the relative detectability of strongly coupled metabolites at 2.35 T and 9.4 T, by 
comparing their respective peak intensities to those of uncoupled singlet resonances.1 
The results further clarify the relative merits of field strengths, as discussed in previous 
publications (Michaelis et al., 1991, Michaelis and Frahm, 2005, Tkád and Gruetter, 
2005) 
  
                                                     
1 A part of this work was accepted for an e-Poster presentation at the 25th Annual Meeting of the 
European Society of Magnetic Resonance in Medicine and Biology, Valencia, October 2008 and also was 
appeared in a review article by Michaelis et al. MICHAELIS, T., BORETIUS, S. & FRAHM, J. (2009) Localized 
proton MRS of animal brain in vivo: Models of human disorders. Progress in Nuclear Magnetic Resonance 
Spectroscopy, In Press, Corrected Proof. 
 
 





In the present study, to achieve high spectral resolution, nonlinear local field 
inhomogeneities were automatically corrected by adjustment of second-order shim 
coils.  
Optimisation of static magnetic field homogeneity (i.e. shimming) was 
accomplished by using FASTMAP. Field homogeneity further improved prior 
spectroscopic measurements by using optimised values for FASTMAP sequence 
parameters. For a 3 mm cubic voxel of interest, stick size of 1.25 mm, repetition time of 
1000 ms, spectral bandwidth of 5000 Hz, and acquisition averages of 2 were set, such 
that the whole adjustment of all linear and quadratic shim coils was accomplished within 
2 min. 
 
3.2.2 Water Suppression 
 
As discussed earlier in chapter 3.1.2., the current version of water suppression 
consists of three successive CHESS pulses (90 90 180), each of which is followed by 
associated spoiler gradients, as has been proposed earlier by (Frahm et al., 1990, 
Moonen and Vanzijl, 1990, Ernst and Hennig, 1995), preceding the STEAM localization 
sequence.  
As stated earlier, the RF amplitude of the CHESS-type water suppression pulses 
and, therefore, the overall water suppression performance could be affected by the RF 
homogeneity profile of the transmitter coil (B1), as well as the magnetic field 
homogeneity (B0) within the voxel. Susceptibility to B1 inhomogeneities was 
considerably alleviated in this work by using a birdcage volume resonator, which allows 
the generation of relatively uniform RF fields together with the advantage of providing 
whole-head coverage, although it still depends on exact calibration of the 90° pulse 
power. The influence of B0 inhomogeneities was reduced by automated, localized 
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shimming of all first- and second-order terms using FASTMAP (fast automatic shimming 
technique by mapping along projections) (Gruetter, 1993, Gruetter and Tkád, 2000) for 
each volume of interest (VOI). In all measurements, efficiency of CHESS pulses was 
optimized with respect to flip angle of the RF pulses after localized shimming, by 
minimizing the signal intensity of residual water in the volume of interest (VOI), just 
prior to final acquisition.  
The efficiency of the current water suppression method was carefully optimized 
on a phantom containing aqueous model solutions of cerebral metabolites, with regard 
to our experimental setup. In addition, performance was monitored and assessed in 
vivo, with respect to CHESS sequence parameters, in order to guarantee sufficient 
suppression over different regions of mouse brain. 
As mentioned earlier, increasing the gradient amplitude would pose a potential 
risk of introducing artifact to the spectrum, due to eddy current effects, without 
improving the suppression performance. Thus, prior to the optimization of the band 
width and the inter-pulse delay, the influence of the amplitude of the spoiler gradient in 
the CHESS sequence on water suppression was investigated in a pilot study. The strength 
of the applied gradients was incremented from 80 mTm−1 to 160, 240 and 320 mTm−1, 
whereas the duration, orientation and polarity remained constant. In vivo magnetic 
resonance spectra obtained from mouse brain were evaluated by considering the 
residual water signal height, as well as the quality of spectra. It turned out that the 
linewidth, baseline and phase remain unaffected by increasing the gradient spoiling 
powers. No significant change was observed for residual water resonance. Based on 
these results, minimum spoiling capacity was chosen because increasing the gradient 
amplitude may cause artifacts due to eddy current effects. Nevertheless, it ensured a 
sufficient dispersion of transverse water coherences, which guarantees robust water 
suppression as well as consistent spectral quality. 
  
 




A series of localized water suppressed proton spectrum with varied bandwidth of 
Gaussian RF pulses were obtained from the centre of spherical phantom of a 10 mm, 
containing a mixture of Lac and Cr (1:2). All the other experimental parameters were 
kept unchanged during measurement. The spectra scaled individually to methyl signal of 
creatine, which was considered unaffected from suppression. Methine quartet of 
lactate, as a resonance of interest, were evaluated to determine the effective water 
suppression bandwidth.  
Influence of this parameter on water suppression performance and critical 
resonances in the vicinity of the water signal were also evaluated in vivo. 8 ml VOI was 
selected in midbrain and all spectra were measured using identical acquisition 
parameters as those used for the phantom experiment, except that repetition time was 
set to 6 sec (see Chapter 2.3 for more details). The measurement repeated several times 
with continuous change of a selected parameter, e.g. RF bandwidth in CHESS water 
suppression sequence. Absorption (real) spectra were manually phased and reported 
directly, without baseline correction or resolution enhancement. 
 
Inter-pulse delay 
After finding the optimal bandwidth for CHESS RF pulses, the influence of 
different intervals between the RF pulses in the current water suppression scheme was 
assessed. This was accomplished by varying the length of the corresponding inter-pulse 
delay between CHESS RF pulses in a series of experiments, without altering 
measurement parameters. Quality of water suppression was verified in a phantom, as 
mentioned previously, by comparing the signal intensity of the residual water obtained 
at different inter-pulse delays. Fully relaxed spectra (TR = 10000 ms) were acquired from 
a 125 μL (5 x 5 x 5 mm3) volume of interest (VOI). Interval values were varied from 25 to 
225 with increments of 25 ms (part of data not shown for simplicity), whereas water 
suppression bandwidth was kept constant at 350 Hz (TE = 10 ms, 8 scans). Spectra were 
individually scaled to the intensity of the methyl signal of creatine as a reference.  
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This procedure was repeated to verify suppression performance in a in vivo 
condition by analysis of a series of spectrum, measured by using the same parameter for 
CHESS sequence. 
Settings of the delays were verified by the analysis of a mouse brain spectrum. In 
vivo 1H NMR spectra of the healthy mouse brain were measured using STEAM with TE = 
10 ms. A VOI size of 2.7 × 2.3 × 2.5 mm localized in the central thalamus. In the final 
version of water suppression, utilizing Gaussian pulses of duration 7.83 ms, with 
bandwidths of 350 Hz and interleaved outer volume suppression module enabled a 
minimum inter-pulse delay of 50 ms. Overall duration of the CHESS module was 147 ms. 
The inter-pulse delay was incremented as indicated in the Figure 3.9, while keeping the 
suppression bandwidth constant (350 Hz). 
For each measurement, Flip angle adjustment was performed to balance the 
effect of T1 relaxation (Moonen and Vanzijl, 1990). Choosing the shortest feasible inter-
pulse delay enhanced T1 insensitivity, in addition to shortening the entire water 
suppression module. 
The current water suppression scheme {τ, τ, 0.87τ; θ, θ, 2θ}, suggested by Ernest 
et al (Ernst and Hennig, 1995), was compared to that of equidistant timing type {τ, τ, τ; θ, 
θ, 2θ}. Therefore, only the third inter-pulse delay (the interval between the third RF 
pulse and the start of the localization sequence) differed in two sequences. The values of 
75, 100, and 125 ms were chosen for τ in CHESS sequence, while the bandwidth of the 
RF pulses were kept constant. Then the spectra were compared to those obtained with 
0.87τ for the third inter-pulse delay. Spectra were acquired with 15 ml VOI (2.5 × 2.0 × 
3.0 mm 3) position in the mid brain, within measuring times of 4.3 min each (TR 8,000 
ms, 32 scans). Spectra were processed in magnitude mode and analytically compared on 
the basis of the ratio of intensities of residual water peak, over that of methyl resonance 
of creatine, as reference.  
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3.2.3 Outer Volume Suppression (OVS) 
Problems associated with the suppression of lipid signals from subcutaneous 
fatty tissues have been tackled by various strategies in this work: 
By means of oblique volume of interest, the excitation volume was positioned 
confined to brain regions - especially in the cortical area - in order to exclude 
subcutaneous fat. Localization performance was improved, using adequate amounts of 
crusher gradients to dephase unwanted signal contamination from outside the VOI, in 
conjunction with employing broad band selective RF pulses to alleviate the volume 
misregistration problem, additionally considering a proper applied excitation order of 
coronal–axial- sagittal in pulse sequence and thirdly, placing spatial saturation bands, 
precisely surrounding the volume to suppress any confounding signal (Connelly et al., 
1988, Duyn et al., 1993, Posse et al., 1993, Shungu and Glickson, 1993).  
 
 
Figure 3.4: Schematic illustration of the employed three outer volume suppression (OVS) blocks (marked 
by the dashed line) used to reduce contamination arising from outside of volume of interest. OVS block 
applied after each CHESS element and comprised of six 1.0 msec hyperbolic secant RF pulses. Each pair of 
pulses selected the sides of the voxel in different directions.  
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On the latter approach, excitation of magnetization from unwanted regions of 
the brain was followed by rapid dephasing, pursuant to applied crusher gradients. In this 
work, CHESS water suppression pulses were interleaved with three blocks of outer 
volume suppression, as illustrated in Figure 3.4. Hence, the improvement in localization 
performance was particularly obtained in the regions closest to the skull  
The OVS comprised of 37 msec blocks with six 1.0 msec full-passage hyperbolic secant 
band-selective pulses, with 90° nominal flip angle and a bandwidth of 20 kHz in each, 
followed by a crusher of 10 msec of amplitude 40 mTm−1. The OVS module extended 
over 3 mm around the VOI, with a 0-mm gap to the voxel. The first two pulses selected 
the sides of the voxel in the right–left direction, and the second and third pairs selected 
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3.2.4 The relative detectability of strongly coupled 
metabolite resonances in proton MR spectra at low- and 
high-field strength 
 
Fully relaxed, localized proton MRS (STEAM) was performed at 2.35 T and 9.4 T. 
Solutions of metabolite mixtures of Ins:Cr (50:50 mM), Glc:Cr (50:50 mM) and 
NAA:Glu:Gln (50:50:25 mM) were investigated in vitro. Line broadened in vitro MR 
spectra (6 Hz and 12 Hz for 2.35 T and 9.4 T, respectively) were compared to MR spectra 
of NMRI mouse brain in vivo. Line-broadened versions of spectra were produced by 
multiplying exponential decay function (12 Hz and 6 Hz for 9.4 T and 2.35 T, respectively) 
to render them representative of limited spectral resolution in vivo (which is reflected in 
e.g., broaden line-width) at each field strength, with a modification to the method 
described previously (Michaelis et al., 1991). 
2.35 T: MRBR 4.7/400 mm magnet (Magnex Scientific, Abingdon, England), 
AVANCE II (Bruker BioSpin, Ettlingen, Germany). In vitro MRS was performed with a 10 
cm Helmholtz transmit/receive coil (TR/TE/TM = 10000/10/10 ms, 10 x 10 x 10 mm3, 64 
accumulations). In vivo MRS was performed with a 10 cm Helmholtz coil for RF excitation 
in conjunction with a 16 mm surface coil for signal reception (TR/TE/TM = 6000/20/10 
ms, 4.0 x 3.0 x 4.0 mm3) in a central position of the forebrain (512 accumulations). 
9.4 T: 94/30 USR BioSpec, AVANCE II (Bruker BioSpin, Ettlingen, Germany). In 
vitro MRS was performed with a 72mm quadrature birdcage transmit/receive coil 
(TR/TE/TM = 15000/10/10 ms, 8 x 8 x 8 mm3, 16 accumulations). In vivo MRS was 
performed with a 72mm quadrature birdcage coil for signal excitation and a quadrature 
mouse brain surface coil for signal reception (TR/TE/TM = 6000/10/10 ms) in a central 
position of the forebrain (4.0 x 3.0 x 4.0 mm3, 32 accumulations) and in the 









Figure 3.10 elucidates the putative role of localized second-order shimming to provide 
superior spectral resolution and sensitivity, compared to the one where only global 
shimming were applied, to refine the static field. In addition, uncompensated 
inhomogeneity of the B0 magnetic field results in imperfect water suppression. This is 
largely due to the frequency-selective mechanism of employed CHESS pulses. Efficient 
shim system (shim coils and shim drivers) was capable of producing maximum shim 
strengths of X = 8741 Hz/cm, Y = 8715 Hz/cm, and Z = 8651 Hz/cm for the linear shim 
terms and X2_Y2 = 698 Hz/cm2, ZX = 3715 Hz/cm2, Z2 = 1243 Hz/cm2, ZY = 2466 Hz/cm2, 
XY = 557 Hz/cm2 for the second-order ones. Optimal application of this shim system 
resulted in the linewidths (FWHM) of 11–14 Hz for the unsuppressed water signals from 
most of the brain regions of mice in vivo. For most metabolites in aqueous solutions (27 
ml), reproducible water linewidths of 1.5–2.0 Hz were achieved. 
 




Figure 3.5: The effect of high-order shimming on spectral resolution and sensitivity of spectrum, obtained 
using localized proton MRS (STEAM, TR/TE/TM=6000/10/10 ms, 15.5 μl VOI, 2 × 128 accumulations) from 
the thalamus of a mouse in vivo at 9.4 T. The suppression of the water signal after second-order shimming 
using FASTMAP (top) is clearly superior to that without it (bottom, only with global shimming). Each 
spectrum is individually scaled to the largest peak for comparison. 
 
 
3.3.2 Water Suppression 
Bandwidth 
Figure 3.6 depicts proton spectra of a mixture of lactate (Lac) and creatine (Cr), 
acquired with different bandwidths of Gaussian-shaped CHESS pulses. In order to 
eliminate the problem arising from different phasing, the spectra were presented in 
magnitude mode and shifted along the chemical shift axis to a different degree for a 
better visualization of suppression effect. Residual water signal served as chemical shift 
reference. Comparison of the quartet signal of Lac shows a decrease in amplitude when 
the suppression band width of  
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Figure 3.6: Proton NMR spectra of a 1:1 mixture of lactate (Lac) and creatine (Cr) at different water 
suppression bandwidths ranging from 300 to 450 Hz. (9.4 T, VOI 5 × 5 × 5 mm
3
, TR/TE/TM = 10,000/10/10 
ms, 32 transients) displayed in magnitude mode. For a better visualization of the results, the spectra 
acquired with 300, 400, and 450 Hz bandwidth were shifted along the chemical shift axis by -15, +15, and 
+30 Hz, respectively. Chemical shifts are given in parts per million (ppm) and referenced to residual water 
signal. While the heights of the quartet signal of Lac at 350 Hz (arrow) remain unchanged compared to 
those at 300 Hz, a decline of Lac can be seen in spectrum obtained with water suppression band width 
more than 350 Hz.   
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greater than 350 Hz is applied. The chemical shift difference between the water 
resonance and methine quartet of lactate in in vitro is equivalent to that of water and 
methylene singlet resonance of creatine in in vivo condition. Therefore, as it can be 
concluded from Figure 3.7, CH2 resonance of creatine remained intact from attenuation, 
by choosing 350 Hz bandwidth for CHESS pulses, while water signal was eliminated 
efficiently. 
 
Figure 3.7: In vivo water-suppressed 
1
H MR spectra of the mouse brain measured using STEAM with 
different bandwidth of CHESS pulses to demonstrate effect of this parameter on overall water 
suppression. Other parameters: 9.4 T, VOI 40 × 25 × 30 mm
3
, TR = 6000 ms, 256 accumulation. The full 
chemical shift range of the spectra is shown to demonstrate the accessible water suppression under the 
experimental conditions used.  
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Inter-pulse delay 
The series of water-suppressed proton spectra in Figure 3.8 demonstrates the 
inter-pulse delay dependence of CHESS water suppression sequence. Despite the 
marked changes that occurred in residual water in shorter inter-pulse delay, no changes 
in the peak height of Lac and Cr resonances were observed. 
 
Figure 3.8: Proton NMR spectra of a 1:1 mixture of lactate (Lac) and creatine (Cr) at different inter-pulse 
delay of CHESS water suppression sequence. (9.4 T, VOI 5 × 5 × 5 mm
3
, TE=10 ms, TR= 10,000 ms, 8 scans). 
interval value was varied from 25 to 225 with increment of 25 ms (part of data not shown for simplicity) 
whereas water suppression bandwidth was kept constant at 350 Hz. Magnitude spectra presented to 
obviate any phase error from the signal and scaled to the creatine (Cr) intensity for comparison. Chemical 
shifts are given in parts per million (ppm) and referenced to residual water signal. Improved water 
suppression was observed in spectrum obtained with the shortest possible inter-pulse delay of CHESS 
pulses.   
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As can be seen from the residual water signals in Figure 3.9, the same holds for in 
vivo condition, but is not quite as salient as observed in the phantom study. The 
minimum possible inter-pulse delay of 50 ms, considering the time required for the 
interleaved outer volume suppression (OVS) part of the sequence, gave rise to sufficient 
suppression of water resonance. 
 
Figure 3.9: In vivo water-suppressed 
1
H MR spectra of the mouse brain measured using STEAM with 
different inter-pulse delay of CHESS water suppression sequence to demonstrate effect of this parameter 
on overall water suppression. Other parameters: 9.4 T, VOI 2.7 × 2.3 × 2.5 mm
3
, TR = 6000 ms, 256 
accumulation. The full chemical shift range of the spectra is shown to demonstrate the accessible water 
suppression under the experimental conditions used. 
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It is of note that no significant difference in suppression performance was observed 
between the equidistant timing scheme and the fined tuned one {τ, τ, 0.87τ} at all 
selected inter-pulse delay (τ). 
 
3.3.3 Outer Volume Suppression (OVS) 
 
In close analogy to the CHESS, by repeating the OVS module three times, the sensitivity 
to B1 field inhomogeneity was reduced and therefore, guarantees a successful 
elimination of spurious signal from outside the desired region of interest, predominantly 




Figure 3.10: Effect of application of outer volume suppression (OVS) on localization performance and 
spectral quality. Localized proton MRS (9.4 T, STEAM, TR/TE = 6000/10 ms, 3.0 × 1.2 × 3.0 mm
3
, 64 
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3.3.4 The relative detectability of strongly coupled 




Phantom Experiments  
Inositol 
 
Proton MR spectra of a mixture of Ins and Cr obtained at both field strengths, 
with and without line broadening, are depicted in Figure 3.11. A doublet-of-doublet 
centered at 3.52 ppm and a triplet at 3.61 ppm are the two prominent multiplets of Ins 
at 9.4 T and each of them correspond to two protons. This complex multiplet resonance, 
merges into an apparent singlet resonance at 2.35 T. As a consequence, the peak 
intensity ratio of Ins to Cr at 2.35 T is decreased by about 50% at 9.4 T, after line 
broadening to in vivo conditions. 
In addition, the intensity of the triplet at 3.27 ppm, originating from the 5CH 
proton, reduced significantly at 2.35 T. This triplet is typically obscured by the prominent 
singlet of the trimethylamine group of choline-containing compounds (Cho) at 3.21 ppm 
and the triplet of taurine (Tau) centered at 3.25 ppm. The 2CH triplet at 4.05 ppm 
remains at 2.35 T, however, it overlaps with the methine quartet of lactate and could be 
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Figure 3.11: (Left) Localized proton MRS of solution with 1:1 mixture of myo-inositol (Ins) and 
creatine (Cr) at 9.4 T (TR/TE = 15000/10 ms) and at 2.35 T (TR/TE = 10000/10 ms) and (right) their line 
broadened versions produced by multiplying exponential decay function (12 Hz and 6 Hz for 9.4 T and 2.35 
T, respectively) to render them representative of in vivo linewidth under the influence of limited 
resolution in each field strength. The peak intensity ratio of Ins to Cr at 2.35 T is decreased by about 50% 




In analogy to Ins, similar reductions apply to the strongly coupled resonances of 
Glc, as shown in Figure 3.12.  
The fully relaxed, localized proton STEAM spectrum of an aqueous solution of a 
1:1 mixture of glucose and creatine, acquired at 9.4T, significantly differs from that at 
2.35 T. The strongly coupled resonances of glucose appear in the range of 3.2–3.88 ppm 
at 9.4T. Instead, in light of strong coupling effects at lower fields, the appearance of the 
respective resonances efficiently simplified at field strength of 2.35 T. Namely, doublet-
of-doublets, centered at 3.23 ppm, disappears at low field whereas its remaining 
complex multiplet pattern, convert to apparent singlet at 3.43 and 3.80 ppm. In 
 
Localized 1H MRS at high-field                                                                                                                            43 
 
addition, these prominent resonances can be clearly observed in line-broadened version 
of spectra, which imitate the in vivo resolution. 
However, these apparent glucose singlets overlap with S-CH2 resonances of Tau 
α-CH resonances from Glu and Gln, respectively (Gyngell et al., 1991b, Tkád and 
Gruetter, 2005, Michaelis et al., 2009). 
 
 
Figure 3.12: Localized proton MRS of a 1:1 mixture of glucose (Glc) and creatine (Cr) at 2.35 T (TR/TE = 
10000/10 ms) and at 9.4 T (TR/TE = 15000/10 ms) and their line broadened versions. The peak intensity 
ratio of Ins to Cr is clearly lower at 9.4 T than at 2.35 T. 
 
 
 Glutamate and Glutamine 
Glutamate and glutamine have similar structures and are considered to be 
examples for strongly coupled metabolites. Both have two methylene groups and a 
methine group that constitutes the strongly coupled AMNPQ spin system (Thompson 
and Allen, 1998, Govindaraju et al., 2000, Thompson and Allen, 2001). This strong scalar 
coupling interaction leads to a complex 1H spectrum with distributed signal over many 
low intensity multiplet resonances.  
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Fully relaxed proton MR spectra and their corresponding line-broadened version 
of a 2 : 2 : 1 mixture of N-acetylaspartate (NAA), glutamate (Glu), and glutamine (Gln) 
are shown in Figure 3.13. Comparing a spectrum obtained in both field strengths, 
illustrates the assignment problem, as a result of completely different spectral patterns 
in different field strengths. Strongly coupled multiplets, originating from two methylene 
groups of Glu, are closely grouped around 2.04 and 2.35 ppm, while those of Gln are at 
2.12 and 2.45 ppm.  
 
 
Figure 3.13: Localized proton MRS of a 2:2:1 mixture of N-acetylaspartate (NAA), glutamate (Glu), and 
glutamine (Gln) at 2.35 T (TR/TE = 10000/10 ms) and at 9.4 T (TR/TE = 15000/10 ms) and their line 
broadened versions. The improved separation of the Glu (2.35 ppm) and Gln (2.45 ppm) multiplets at 9.4 T 
is clearly visible. 
 
Since the resonances of glutamate and glutamine overlap with those of NAA 
aspartyl moiety and GABA in this range, specific identification of their individual signal 
contributions in vivo is, thereby, complicated. Contrary to the myo-Ins and glucose 
spectral behavior at high field, improved separation of the Glu (2.35 ppm) and Gln 
multiplets (2.45 ppm) at 9.4 T leads to a better detectability and a greatly enhanced 
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quantification accuracy. On the other hand, since the separation of Glu and Gln becomes 
very difficult at low field, their contribution is, therefore, commonly combined 
(designated Glx), which improves quantification accuracy. 
 
 
In Vivo Experiments 
Figure 3.14 compares in vivo localized proton MR spectra of the healthy mouse 
brain obtained at two different field strengths. Major metabolites, e.g., tNAA, tCr, Cho, 
Ins, Glc, Tau, and Glu, can be readily identified. The better identification of Ins and Glc at 
2.35 T, as well as Tau and Glu at 9.4 T, is demonstrated in proton MR spectra of mouse 
brain in vivo. The ability to acquire sufficient SNR in short measuring time is exemplified 
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Figure 3.14: Localized proton MRS of the brain of mice (from the same strain: NMRI) in vivo at different 
field strengths. In comparison to (top) 2.35 T (STEAM, TR/TE = 6000/20 ms, 512 accumulations), (middle) 
9.4 T (STEAM, TR/TE = 6000/10 ms) allows for a much lower number of accumulations (32 accumulations) 
for the same volume-of-interest placed in the forebrain (4.0 × 3.0 × 4.0 mm
3
) as described by Schwarcz et 
al. (Schwarcz et al., 2003). The spectral resolution at 9.4 T is worse (which is reflected in broader line-
width) than those from smaller VOI shown in other figures because the large VOI is composed of different 
brain structures (e.g., gray and white matter, CSF), where a better resolution is hard to achieve. (Bottom) 
alternatively, high-field MRS provides sufficient SNR for a much smaller volume (2.0 × 1.2 × 2.2 mm
3
 
covering the hippocampus) at still reduced measuring time (128 accumulations). 
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3.4 Discussion 
The improvement in local static field homogeneity, achieved by FASTMAP 
shimming, resulted in high and reproducible spectral resolution, which can be seen from 
the highly resolved spectra, obtained from different brain regions or from model 
solutions (Figs. 4.3 and 4.4). Consequently, efficient water suppression was attained as a 
result of improvement in crusher gradient performance in frequency-dependent water 
suppression (Moonen et al., 1992). For the selected small VOIs which were studied, first 
and second-order terms were sufficient for compensation of field inhomogeneities. 
The achieved optimal water suppression allowed a reliable detection of critical 
metabolite signals, despite their close proximity to the water resonance. CH2 resonance 
of creatine remained intact from attenuation by choosing 350 Hz bandwidth for CHESS 
pulses, while the water signal was eliminated efficiently (see Fig 3.6.). This approach 
guaranteed that optimal bandwidth for CHESS pulses were used for water suppression. 
Further, the quality of spectra (e.g., the baseline) from different regions of the mouse 
brain confirmed that the applied water suppression scheme is effective over a range of 
T1 and B1 values, expected for different brain regions. This is mainly achieved by 
judicious choice of inter-pulse delay, between each Gaussian CHESS pulse. Since the 
selected timing scheme was found to have an insignificant effect on the suppression 
performance, {τ, τ, 0.87τ; θ, θ, 2θ} scheme was preferred in all measurements to shorten 
the sequence length. Therefore, signal strength was well preserved within the 
localization procedure.  
The 20 kHz bandwidth of OVS RF pulses (pulse duration of 1.0 ms) reduced the 
chemical shift displacement error of the OVS to values comparable with chemical 
displacement error of the VOI. STEAM localized spectra of cortical areas that are devoid 
of lipid contamination, justified efficacy of the incorporated OVS scheme. This was 
further supported by the result shown in Figure 4.4, showing data from different 
locations and VOI sizes. This approach allowed us substantial improvement in detection 
and quantification of lactate and alanine in different regions of the mouse brain. 
The superior peak intensity ratios of Ins and Glc to Cr at 2.35 T refer to a better 
relative detectability of their respective resonances at low magnetic fields. This is due to 
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the fact that their complex multiplet pattern simplifies to an apparent singlet at low 
field. In contrast, the larger chemical shift dispersion at 9.4 T yields an improved 
detectability of Glu and Tau resonances at high field strengths. With regard to the other 
major metabolites with singlet resonances, the relative detectability is field-
independent. In general, the most important advantage of a high field is a gain in SNR. 
This provides access to adequately small VOIs, which allows for a metabolic assessment 
of regional structures of mouse brain, such as the hippocampus. Alternatively, the gain 
in SNR may be exploited for detection and quantification of weakly represented 
metabolites (e.g Ala, NAAG, GABA, Asp, scyllo-Ins), which cannot be identified at 2.35 T 








Regional metabolite concentrations of 
mouse brain in vivo  
4.1 Introduction 
 
In order to understand the structure and the function of the central nervous system, in 
the context of genetic information, a growing number of mutant mice are generated and 
investigated. Characterization of genetically modified mice is, thus, of special 
importance for a better understanding of pathological mechanisms, which underlie 
human brain disorders. To fully exploit the rapid progress in neurogenetics, the 
development of in vivo assessment techniques, such as noninvasive NMR technology, is 
highly desirable. In this regard, a number of studies using transgenic mice have 
demonstrated a great potential of in vivo MRI for providing detailed morphologic 
insights into the brain. The non-invasiveness of NMR has allowed a repeated assessment 
of behaving mice, which may allow an assessment of longitudinal treatment on animal 
models of chronic human disorders. Despite this proven advantage, there are only a 
limited number of published proton MRS studies on the brain of mice in vivo, probably 
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due to rigorous requirements. In addition to the technical requirements described in 
Chapter 3, the anesthesia may be much more challenging for MRS because cerebral 
metabolism can be more susceptible to an altered physiological condition or to a 
pharmacological effect of anesthetics, in comparison to cerebral morphology. 
Furthermore, the small size of the brain of mice poses a specific challenge for VOIs to be 
localized within an even smaller subdivision of the brain. In previous work, which 
employed the smallest VOI for mouse brain in vivo, metabolite concentrations were 
determined for only four different regions (Tkád et al., 2004). To overcome these 
challenges, a special experimental protocol must be developed, which includes (i) 
selection of suitable transmit and receive coils, (ii) an anesthesia method, (iii) 
maintenance of body temperature, and (iv) reproducible placement of the receive coil, 
together with the heads of mice. In addition, T1 and T2 relaxation times are determined 
for systematic errors in metabolite quantification to be reduced because (i) the water 
content of the tissue in vivo, (ii) the signal attenuation between the tissue in vivo and the 
metabolite model solution in vitro, and (iii) the partial volume effect of the cerebrospinal 
fluid, may influence the quantification.  
 High reproducibility is essential to unveil subtle variation of neurochemical 
profiles in the longitudinal investigations of physiological or pathophysiological 
processes. Intra-individual variability in the data from single-voxel localized 1H MRS 
examinations are generally associated with various factors, including biological 
variability, instrumental instability, animal and the VOI positioning, operator variability 
and spectral analysis methods. Several studies have been conducted to demonstrate the 
degree of reproducibility in 1H MRS of the human brain in vivo, either using different 
localization sequences, locations and timing parameters (Geurts et al., 2004, Inglese et 
al., 2006) or different field strengths of 1.5 T (Alger et al., 1993, Brooks et al., 1999, 
Geurts et al., 2004, Hammen et al., 2005, Helms, 2000, Kreis et al., 2005, Schirmer and 
Auer, 2000), 2.0 T (Choi and Frahm, 1999, Michaelis et al., 1993b), 3.0 T (Milne et al., 
2009, Hancu et al., 2005), 4.0 T (Bartha et al., 2000, Bartha, 2007), and 7.0 T (Tkád et al., 
2009, Tkád et al., 2002). So far, however, only a few studies have experimentally 
investigated the intra- and inter-individual variability in rodent brain in vivo (Pfeuffer et 
al., 1999, Öz et al., 2010, Hong et al., 2011b). Therefore, in the present study, Intra- and 
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inter-individual reproducibility of MR spectroscopic acquisition protocol and 
corresponding LCModel data analysis were assessed, based on the variability of 
metabolite concentrations in healthy mouse brain at 9.4 T using a localization sequence, 
based on stimulated echo acquisition mode [STEAM]. Absolute metabolite 
concentrations (mean ± SD), the coefficients of variation (CV) and Crame´r–Rao lower 
bounds from intra-individual studies were compared to those from inter-individual 
studies, obtained under similar experimental conditions. 
 
4.2 Materials and Methods  
Animal preparation 
All studies were performed in accordance with German animal protection laws 
and approved by the responsible governmental authority. The experiments were 
performed on nine adult healthy female NMRI mice (body weight in the range 34-38 g). 
Anesthesia was induced, using a chamber pervaded with 5% isoflurane in oxygen. The 
mice were intubated with a purpose-built polyethylene endotracheal tube and artificially 
ventilated afterward. Anesthesia was maintained with 1 to 1.5% isoflurane in a 1:1.5 
mixture of oxygen and ambient air. The animals were then placed in a prone position on 
a home-built palate holder, equipped with an adjustable nose cone and ear bars. This 
sophisticated stereotaxic animal cradle ensured stability and reproducibility of the 
experimental setup by properly immobilizing the animal's skull during measurements. 
Body temperature was maintained constant around 37°C using heated water blankets, 
placed over the animal and connected to a temperature-controlled circulating water 
bath. A rectal thermosensor was utilized for temperature verification throughout the 
experiment. Respiration was monitored by a pressure transducer, which was fixed to the 
animal’s chest. Details of the experimental setup used for in vivo MRI/MRS of mouse 
brain at 9.4 T are shown in Figure 4.1. 
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Figure 4.1: Experimental setup for localized 
1
H MR spectroscopy of mouse brain at 9.4 T. Radiofrequency 
excitation and signal reception were accomplished by a quadrature birdcage coil (not shown) and a 
quadrature mouse brain surface coil (1), respectively. The body temperature was maintained constant 
using a heated water blanket (2) positioned around the body. The animals were anesthetized and 
intubated with a polyethylene endotracheal tube (3) and artificially ventilated. Their heads firmly fixed by 
means of a home-made stereotaxic palate holder with an adjustable nose cone. Source: from Michaelis et 
al., (Michaelis et al., 2009). Courtesy of Dr. Roland Tammer (rtammer@gwdg.de). 
 
 
Proton MR Spectroscopy 
The experiments were performed at 400 MHz on a 9.4 T horizontal superconducting 
magnet with 30 cm bore size (Bruker Biospec Avance ll 94/30; Bruker, Karlsruhe, 
Germany) and equipped with a 12 cm inner diameter self-shielded gradient coil insert 
(Resonance Research Inc, Billerica, MA, USA), capable of supplying up to 400 mTm−1 in 
80 μs rise time. RF amplifier with 2 kW peak power was used because preliminary study 
has shown that it allows shorter slice-selection RF pulse, which consequently reduces 
the extent of the chemical shift displacement error, in comparison with standard 1 kW 
RF power amplifier. 
A commercially available, 72 mm quadrature volume coil was used for excitation 
and a quadrature mouse brain surface coil (Bruker, Karlsruhe, Germany) was used for 
signal detection. For the measurement of 1H NMR spectra from forebrain regions (e.g., 
cerebral cortex, striatum, thalamus, and hippocampus), the surface coil was located 
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upon the head of the mouse, as shown in Fig. 4.1. For spectra from hindbrain regions 
(e.g., cerebellum and brainstem), it was relocated caudally to maximize signal reception. 
The system was interfaced to a Linux operating system, running Topspin 1.5 and Para 
Vision 4.0 imaging software (Bruker Biospin, Germany). 
Axial and sagittal T2-weighted multi-slice RARE (Rapid Acquisition with Relaxation 
Enhancement) (Hennig et al., 1986) images were obtained to carefully select VOI 
positions for localized proton MRS. The timing parameters used to collect the MRI data 
were TR/TE = 4200/14 ms, RARE factor = 8, number of averages = 2, slice thickness = 0.5 
mm, field of view = 26 × 26 mm, matrix size = 128 × 128. Figure 4.2 shows typical 
placement of the volumes-of-interest (VOIs) for 1H-MRS of ten different brain regions, 
with sizes ranging from 4.2 to 15.5 μl. Since no lateralisation of metabolite levels in 
normal adult brain was observed in previous studies (Choi and Frahm, 1999, Nagae-
Poetscher et al., 2004), VOIs were unilaterally localized in the left hemisphere for the 
cerebral cortex (5.6 μL, “Lateral Cortex”), callosal fibres (4.2 μL), striatum (11 μL), 
thalamus (9.2 μL, “Lateral Thalamus”) and hippocampus (4.6 μL). In addition, VOIs are 
selected for the medial part of the frontal cortex (6.75 μL, “Medial Cortex”), corpus 
callosum (4.76 μL), thalamus (15.52 μL, “Medial Thalamus”), brainstem (8.25 μL) and 
cerebellum (6.12 μL). Lateral VOIs were placed in the left hemisphere of the mouse 
brain. As the “Lateral Cortex” and the “Medial Cortex” were close to the scalp, these 
VOIs were carefully placed to exclude the fat tissue of the scalp. For the corpus callosum 
and the brainstem, the VOI was tilted around the X axis in order to achieve a better 
localization. For the “Lateral Cortex” and the callosal fibres, a tilt around the X axis, along 
with a tilt around the Z, was applied. This double-oblique localization was necessary for 
the “Lateral Cortex” to exclude the neighbouring white matter, whereas it enabled an 
optimal exclusion of the grey matter from the “callosal fibres”. As far as the brainstem 
was concerned, the VOI included both the pons and the medulla oblongata. With regard 
to the cerebellum, the VOI covered its medial portion, including the vermis. To minimize 
the inter-individual variability in the placement of these VOIs, a number of anatomical 
structures were used as landmarks (e.g. the midsagittal plane, the lateral wall of the 
anterior horn of the lateral ventricle, the rostral border of the dorsal hippocampal 
formation, and the border between the hypothalamus and the basal cistern). 
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The oblique, rather than orthogonal localization, may lead to an inadequate 
performance which causes a variation in concentration, although it offers a potential 
advantage of accurate localization with optimal SNR, while minimizing partial volume 
effect (i.e., contamination of CSF or other brain tissue). Optimization of VOI can facilitate 
selection of any desired volume. Therefore, the performance of oblique localization was 
investigated. To ascertain the possible effect of choosing oblique VOI on the 
corresponding localization performance, VOI of 27 μL were measured with different 
angles and directions, with respect to the main coordinate axes x, y, z.  
  
Table 4.1. Concentration of creatine in 6 different oblique VOI determined by LCModel 





    0 100.0 ± 2.1 
X +45 95.7 
X −45 102.0 
Y +45 99.0 
Y −45 94.9 
Z +45 96.8 
Z −45 98.3 
 
The absolute creatine concentration obtained from an orthogonal VOI in the 
center of a 3-cm diameter glass sphere (filled with distilled water containing 50 mM 
creatine) was normalized to 100. The quantitative analysis of the determined 
concentrations, summarized in Table 4.1, revealed that variation of concentration 
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Figure 4.2: T1-weighted 3D multi-slice RARE images (TR/TE = 4200/14 ms, RARE factor = 8, matrix size = 
128 × 128) of the mouse brain (NMRI) representing typical placement of volumes of interest (VOIs) 
selected for 
1
H-magnetic resonance spectroscopy of the Medial Cortex (a), corpus callosum (a), striatum 
(a,c), hippocampus (b,c), Medial Thalamus (b), Cerebellum (c,d), Lateral Cortex (d), callosal fibers (d), 
Lateral Thalamus (d), brainstem (d). 
Two sequential fully relaxed short echo-time proton MR spectra (STEAM, 
TR/TE/TM=6000/10/10 ms, 128 averages) were obtained from the corresponding brain 
regions. For each measurement, spectral width was set to 5000 Hz and 4096 data points 
were acquired. The unsuppressed water signal, measured from the same VOI, was 
exploited as an internal reference for quantification (Barker et al., 1993, Soher et al., 
1996). In order to alleviate unwanted effect of frequency drifting or shim instability, 
during acquisition on spectral line width, the number of accumulations was restricted to 
128 for each recording. Mean spectra were created from acquired individual in vivo 
spectra, consisting of 2 × 128 for each animal, yielding satisfactory signal-to-noise ratio 
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(SNR) as well as reliability of metabolite detection and quantification. Adjustment of all 
first and second order shim terms were performed automatically for each VOI using 
FASTMAP (Gruetter, 1993) method. Optimization of field homogeneity (shimming) 
routinely resulted in unsuppressed water signal line widths (full-width at half-maximum 
[FWHM]) of 11–14 Hz and 9 Hz for metabolites in vivo (measured on the Cr/PCr CH3 peak 
at 3.0 ppm). Optimized CHESS-type (Frahm et al., 1990, Ernst and Hennig, 1995) method 
was employed for water suppression and to improve quality of localization, interleaved 
with outer volume saturation. Both preceded the STEAM sequence. The parameters 
used for MRS data acquisition and FASTMAP shimming are a consequence of method 
optimization, described in the third chapter, and therefore, are only briefly outlined 
here. 
 
Quantification of metabolites 
The resulting in vivo spectra were analysed in the frequency domain by using 
LCModel 6.2-0 (Linear Combination of Model spectra of metabolite solutions in vitro). 
This user-independent and fully automated fitting routine estimates absolute metabolite 
concentrations by incorporation of a priori knowledge, which are usually referred to as a 
“basis set” into the data evaluation (Provencher, 1993). Basis spectra are obtained from 
individual metabolites at known concentration in aqueous solution, under identical 
experimental conditions as those in the in vivo acquisition. LCModel obtains an optimal 
fit to the in vivo spectra by finding the smoothest line shape and baseline, consistent 
with the data, using a constrained regularisation algorithm (Provencher, 2001). The 
method takes advantage of full spectral features of each individual basis spectrum for 
evaluation, rather than individual resonances. Therefore, it allows discrimination 
between metabolites with overlapping signals. Raw data obtained from measurement 
was directly supplied to LCModel. Adjustment of phases, determination of referencing 
shift, estimation of baseline and the uncertainties in the concentrations (Crame´r–Rao 
lower bounds), as well as eddy current correction, are automatically accomplished. 
Unsuppressed water signal, measured from the same VOI under identical 
conditions, was used for metabolite quantification, assuming a constant brain water 
 
Regional metabolite concentrations of mouse brain in vivo                                                                                             57 
 
concentration of 43.7 mol/L (Schwarcz et al., 2001, Schwarcz et al., 2003). Hence, 
concentrations are expressed as mM, i.e., millimoles of metabolite per volume of tissue 
[mmol/ (litre VOI)]. Using water referencing inherently overcome problems arising from 
different coil loadings, different voxel sizes in addition to regional inhomogeneities in 
surface coil sensitivity profile. Therefore, it allows feasibility of reliable and accurate 
absolute quantification with use of surface coil (Kreis et al., 1993a, Danielsen and 
Henriksen, 1994, Kreis, 1997, Michaelis et al., 1999, Pfeuffer et al., 2004, Jansen et al., 
2006). 
Spectra of 16 brain metabolites were included in LCModel basis-set: alanine 
(Ala), aspartate (Asp), creatine (Cr), phosphocreatine (PCr), γ-aminobutyric acid (GABA), 
glucose (Glc), glutamate (Glu), glutamine (Gln), glycerophosphorylcholine (GPC), 
phosphorylcholine (PCh), myo-inositol (Ins), lactate (Lac), N-acetylaspartate (NAA), N-
acetylaspartylglutamate (NAAG), scyllo-inositol (scyllo-Ins) and taurine (Tau). 
Furthermore, sum concentrations were evaluated for those metabolites with a strong 
cross-correlation, originating from similarity in their structure and spectral patterns. 
Therefore, the sums of NAA + NAAG, GPC + PCho (total choline-containing compounds), 
PCr + Cr (total creatine) and Glu + Gln were reported. LCModel analysis was performed 
in the chemical shift range of 0.5–4.2 ppm. 
Crame´r-Rao lower bounds (CRLB) of LCModel analysis were used to assess 
accuracy and reliability of the fitting, which is regarded as the metabolites concentration 
estimated errors and reflect the estimated standard deviation (%SD) of the metabolite 
fit (Cavassila et al., 2001, Kreis, 2004, Helms, 2008). CRLB higher than 50% was 
considered as exclusion criterion for metabolite evaluation. Thus, only concentrations 
with CRLB below 50% were taken into account in the analysis. In addition, the residuals 
(original spectrum minus fitted spectrum) for each spectrum were visually inspected for 
presence of spurious artifacts to check adequate convergence of the peak fitting. Other 
rejection criteria, such as poor SNR (<6), existence of strong baseline distortions and line 
widths (full-width at half-maximum peak height, FWHH), which exceeded the 
expectations limits, were applied (Jansen et al., 2006, Poullet et al., 2008). 
To account for the potentially confounding effect of fast relaxing 
macromolecules and mobile lipids on metabolites quantitation in short-echo 1H MR 
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spectroscopy, their corresponding simulated signal were incorporated into the basis set 
of LCModel (Behar and Ogino, 1993, Michaelis et al., 1993b). Regularized spline baseline 
modelling of LCModel imitates most physiological characteristics of short-T1 
macromolecules spectrum (Provencher, 2001). Hofmann et al evaluated the influence of 
using an experimentally determined macromolecule baseline as prior knowledge 
(Hofmann et al., 1999, Hofmann et al., 2002) on metabolite concentration estimation 
and compared the results with conventional LCModel fit. For that reason, in this study, 
no further attempt was made to experimentally include the physiological 
macromolecular pattern in the basis set of LCModel. However, to incorporate measured 
macromolecule signals, one can acquire In vivo metabolite-nulled spectra which, allow 
reliable quantification of macromolecules (Pfeuffer et al., 1999, Auer et al., 2001, Seeger 
et al., 2003). 
 
 
Measurement of the basis set 
Model spectra were recorded from aqueous model solution of alanine (Ala), 
aspartate (Asp), phosphocholine (PCh), glycero-PCh (GPC), creatine (Cr), 
phosphocreatine (PCr), γ-aminobutyric acid (GABA), glucose (Glc), glutamine (Gln), 
glutamate (Glu), glutathione (GSH), myo-inositol (mI), Scyllo-inositol (sI), lactate (Lac), N-
acetylacetate (NAA), N-acetylaspartylglutamate (NAAG), taurine (Tau), 
phosphorylethanolamine (PE), ascorbic acid (Asc), glycine (Gly), acetate (Ace), threonine 
(Thr), propylenglycol (Pgc)and ethanol (Eth), according to Provencher (S. Provencher, 
LCModel & LCMgui User’s Manual, http://s-provencher.com/pages/lcmodel.shtml). 
Spectrum of scyllo-inositol was simulated by shifting the singlet of glycine from 
3.55 to 3.35 ppm. All chemicals were purchased from Sigma-Aldrich and Fluka. 
Metabolites were dissolved separately in an aqueous phosphate buffer (72 mM K2HPO4, 
28 mM KH2PO4), containing 3-(trimethylsilyl)-propanesulfonic acid sodium salt (DSS), as 
chemical shift reference (0 ppm) and pH was subsequently adjusted to 7.20. 200 mM 
sodium formate was added for automatically phasing and scaling of model spectra by 
using its singlet at 8.44 ppm. For choline containing compounds, the phosphate buffer 
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was replaced by 100 mM potassium chloride (KCl). Metabolite signal of the model 
solution was obtained by measuring a VOI size of 3-4 cm3 centrally located in a spherical 
phantom of 11 ml. The scaled spectra from all solutions are presented in Figure 4.3. 
A 72 mm quadrature birdcage coil was used for both signal excitation and 
reception. Fully relaxed basis sets were acquired with sufficiently long repetition time 
(TR=15 s), obviating the need for in vitro T1 relaxation correction but with otherwise 
identical experimental conditions (STEAM, TE/TM=10/10 ms) to those of the in vivo 
measurements. 
Due to the fact that “Auto-Phasing” failed to correctly phase the acquired Basis 
Spectra, accurate values for zero- and first-order phase correction, φ0 and φ1, were 
manually determined for each metabolite in the Basis Set. 
For precise and consistent quantification, concentrations of GPC, NAAG and all 
other prominent singlets were individually calibrated to the CH3 resonance of creatine 
peak. For this purpose, it is necessary to consider how many protons effectively 
contribute to the singlet. This method resolves the ambiguity in determining 
concentration, which arises from the preparation of model solution, i.e., (i) uncertainty 
in the molecular weight of GPC because GPC in vitro needs cadmium chloride adduct, 
and (ii) inaccurate water content value for hydrated compounds, e.g., PCr. It should be 
noted that the method exploits the fact that the concentration of the dissolved 









Figure 4.3: Representative short-echo basis spectra for LCModel, measured with the STEAM sequence 
from model solutions (pH 7.20). (For details and abbreviations, see text.)  
 
 





Figure 4.3: Continued.   
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Assessment of the T1 and T2 relaxations and their impact 
on metabolite quantification 
 
Nevertheless, a precise estimation of water content is essential for absolute 
quantification of metabolite concentration by LCModel because the signal of 
metabolites must be calibrated to that of water. Metabolite signal is supposed to be 
originated mainly from brain tissue, while a localized volume-of-interest may contain, 
not only brain tissue, but also cerebrospinal fluid (CSF). Thus it has been proposed that 
compartmentation information has to be determined on the basis of image 
segmentation (C.W. Brooks et al., 1999, Schuff et al., 2001, Horská et al., 2002) or 
spectroscopy pulse sequence (Hennig et al., 1992). Further, T1 and T2 attenuation of 
water signal may lead to potential errors for accurate absolute metabolite 
quantification. The water content of the localized volume-of-interest may be calculated 
from T1 relaxation time of the brain tissue. 
The water T1 relaxation time was determined in all the aforementioned brain 
structures. A series of STEAM experiments, without water suppression, and with varying 
repletion times of 580, 700, 800, 1000, 1200, 1500, 1700, 2000, 3000, 5000, 6000, 7000, 
8000, 10000, 12000 and 15000 ms were obtained. To yield apparent T1, the water 
signals were fitted to mono-exponential function, according to Equations 4.2 and 4.4. 
Other parameters of the applied STEAM sequence were kept identical: TE = 10 msec, 
mixing time (TM) = 10 msec and 8 accumulations. 
For T2 measurement, peak heights of unsuppressed water FIDs, obtained from 
aforementioned series of STEAM experiments, were fitted to monoexponential decay 
functions. This procedure obviates problems arising from variability of linewidth, due to 
different quality of achieved shimming. 
 
Partial volume effect  
Spectroscopic T2 method was exploited to determine the contributions from 
cerebrospinal fluid (CSF) within the selected volumes. This has been accomplished for all 
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locations - even for the relatively small voxels used in this study. Series of the 
unsuppressed water signal in proton MR spectra were acquired at 12 different echo 
times (10 ms - 1000 ms) and water signal intensities from time-domain data (FIDs) were 
fitted to a bi-exponential model function (Ernst et al., 1993, Kreis et al., 1993b), 
according to the following equation: 
 
𝑆 = 𝑆TE=0,BW . exp  −
𝑇𝐸
𝑇2,BW
 +  𝑆TE=0,CSF . exp  −
𝑇𝐸
𝑇2,CSF
  (4.1) 
 
STE=0,BW and STE=0,CSF are relaxation-corrected signal amplitudes for brain water 
(BW) and cerebrospinal fluid (CSF), respectively. Standard least squares fitting procedure 
was performed with curve-fitting tool of Matlab (Version 7.1; The MathWorks, Inc., 
Natick, MA, USA). Fractional water content of the selected voxel with mixed proportions 
of CSF and brain matter (partial volume averaging) was calculated from the component 
analysis, considering the fact that longer T2 component ascribed to CSF (T2, CSF). 
A survey of potential partial volume contributions from the cerebrospinal fluid 
(CSF) within the investigated VOIs was achieved by analyzing least squares fit of TE series 
data points to a bi-exponential and mono-exponential model functions, according to 
Equations 4.1 and 4.2. The mono-exponential fitting always resulted in better fit and the 
long T2 component of the bi-exponential decay, assigned to CSF, was not detected. 
These findings indicate that localization was optimal and CSF contribution to the 
volumes can be considered to be negligible.  
 
Signal attenuation 
Water attenuation can be regarded as representative of potential error for 
accurate absolute metabolite quantification, whereas unsuppressed water signal served 
as internal reference. To examine influence of relaxation attenuation, transverse 
relaxation times (T2) of water, as well as its longitudinal relaxation (T1), were determined 
in different regions. 
Equation 4.2 describes attenuation of the NMR-visible water signal as a result of 
relaxation effects in STEAM. 
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𝑓T2 = exp  −
𝑇𝐸
𝑇2
  (4.3) 
 
 
𝑓T1 = exp  −
𝑇𝑀
𝑇1
 [1 − exp  −
𝑇𝑅
𝑇1
 ] (4.4) 
 
𝑓T2 and 𝑓T1 indicate corresponding relaxation losses as a consequence of T2 and 
T1, involving those throughout the middle interval (TM), where the delay is within the 
second and third pulses of the STEAM sequence. 
LCModel’s control parameter atth2o, which is basically 𝑓T2 × 𝑓T1, takes care of 
correction for relaxation attenuation of water signals. Owing to the sufficiently short 
echo time (TE=10 ms) and long repetition time (TR=6000 ms) used in all in vivo 
measurements, this attenuation factor was kept constant (ATTH2O=0.7), although, the 
impact of regional variability of the relaxation on this factor was evaluated. 
It is assumed that model spectra were acquired with identical parameters as in 
vivo data and that metabolites possess different relaxivity in in vitro and in vivo 
conditions. As a consequence, pertinent correction factors, induced by residual T2 
relaxation effects 
2








1 exp( / )






























Two major metabolites, glutamate as a strongly coupled one and creatine as an 
uncoupled one, were chosen to exemplify possible correction factors, accounting for the 
differential T2 attenuation between in vivo and in vitro conditions. In the light of 
correction of concentrations for residual T2 relaxation effects, the T2-values were taken 
from literature (Xin et al., 2008) and regional variations in T2 relaxation times of 
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metabolites were disregarded. Diffusion-induced signal attenuation, brought about by 
incorporation of crusher gradient into the TE/2 intervals, was disregarded due to its 
minor contribution and steady presence in employed STEAM sequence (de Graaf et al., 
2001). 
To evaluate the amount of signal attenuation due to relaxation, quantitative 
localized T2 measurements were pursued in vivo for all structures used in this study. T2 
relaxation times of tissue water were obtained by mono-exponential fitting. Table 4.2 
summarizes the T2 relaxation times (mean values and SDs) of water in various mouse 
brain regions measured in vivo at 9.4 T. The results from the analysis, as presented in 
Table 4.2, showed regional differences of brain water T2 relaxation, of which, highest 
values were observed in the cortex, while those of brain stem and cerebellum were at 
the lowest. 
 
Table 4.2 Mean and SD of tissue water proton T2 relaxation times (ms) determined in 
different region of the normal mouse brain in Vivo 
     Structure    
 mcx lcx cc cf st mth lth hc cb bs 
 n=8 n=7 n=9 n=8 n=8 n=9 n=9 n=9 n=8 n=5 
T2 (ms) 36.6 36.0 34.9 35.0 35.4 35.3 33.7 36.0 32.8 33.0 
SD (ms) 0.7 1.0 1.6 1.5 0.7 0.5 0.5 1.1 0.5 0.7 
mcx = medial cortex, lcx = lateral cortex, cc = corpus callosum, cf = callosal fibres, st = striatum, mth = medial 
thalamus, lth = lateral thalamus, hc = hippocampus, cb = cerebellum, bs = brainstem 
 
The estimated longitudinal and transverse relaxation attenuation (𝑓T1, 𝑓T2) of the 
brain tissue water, along with the respective LCModel’s control parameter atth2o, for 
exemplary locations, are given in Table 4.3. Relaxation attenuations for water signal 
were derived by employing measured T1 and T2 values of water, according to Equations 
4.3 and 4.4. 
 
Table 4.3 Water signal attenuation caused by T1 and T2 relaxation and pertinent atth2o 
estimated for medial cortex and brainstem  
Structure T1 (ms) T2 (ms) fT1 fT2 atth2o  
mcx 2002 37 0.95 0.76 0.72 
bs 1709 33 0.96 0.74 0.71 
mcx = medial cortex, bs = brainstem 
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 T1 values for proton spins of metabolites in aqueous solution are much longer 
than those in the brain (Michaelis et al., 1993b, Pouwels and Frahm, 1998, Pfeuffer et 
al., 1999, in 't Zandt et al., 2001). Taken together with the fact that both model spectra 
and in vivo brain spectra are obtained under fully relaxed conditions, using sufficiently 
long repetition times, it dispenses the need of correction for differential T1 relaxation for 
absolute metabolite quantification. 
With regard to T2 relaxation, the total signal loss of water signal at the short TE of 
10 ms is 28% and 29% in medial cortex and brainstem, respectively. To account for this 
attenuation, the corresponding correction factors of 1.03 and 1.01 may be applied in 
metabolite concentration. Therefore, for all the regions, atth2o=0.7, i.e., signal loss of 
30%, was used, because it is unnecessary to measure T1 relaxation time for each region 
and animal. 
Exemplarily, differential T2 attenuations were determined for glutamate and 
creatine CH3 assuming the corresponding mean T2 relaxation times of 190 ms and 376 
ms in vitro together with 89 ms and 113 ms for those in vivo (Xin et al., 2008). The 
resulting signal loss of 6 % (TE = 10 ms) was estimated for these resonances, using 
Equation 4.6 in Sec. 4.2. Consequently, the related correction factor of only 1.06 may be 
derived, which required to be multiplied to their concentrations, which was thus 
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Water content  
The water content of the localized regions was calculated, based on measured T1, 
as suggested earlier by Schwarcz et al in a study of water content quantification of 
vasogenic edema in mouse brain, at 9.4 Tesla. Equation 4.7 indicates the expected 
linearity between the inverse of longitudinal relaxation (1/T1) of the water protons and 
the inverse of the total water content (1/W), where W is the percent concentration of 
water. This was previously presented and experimentally verified at 400 MHz (Schwarcz 







   (4.7) 
 
 
The molar brain water content, essential for absolute quantification, is derived 
from the water content (W), assuming a concentration of 55.6 mol/liter for pure water 
and brain density of 1.047 g/ml (Torack et al., 1976, Brooks et al., 1980, Rieth et al., 
1980, Kreis et al., 1993a). 
Water longitudinal relaxation times (T1) in different regions of the mouse brain 
were determined in vivo at 9.4 T. T1 relaxation times were calculated from selected 
volumes of interest (VOIs) on a mono exponential fitting basis, according to Equations 
4.2 and 4.4. Calculated values ranged from 1709 ms in brain stem to 2002 ms in medial 
cortex. Consequently, corresponding calculated fractional water content, ranged from 
80% to 82%, respectively (Equation 4.7). Assuming a pure water concentration of 55.6 
mol/liter and brain tissue density of 1.047 g/ml (Takagi et al., 1981, Kreis et al., 1993a), 
water content of 42.5 and 43.5 mol/liter were yielded for the regions stated before. 
From the repeated measurements of water content in the cortical area, individual 
reproducibility error was assessed. The small standard deviations of less than 1% 
demonstrated the excellent reproducibility of the experiments. As described in section 
4.2, water signal was used as an internal reference for quantification of metabolite 
concentrations.  
The obtained value turned out to be in line with 43.7 mol/L, determined by 
Schwarcz et al. (Schwarcz et al., 2001, Schwarcz et al., 2003). Therefore, this value was 
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used for the quantification of metabolites from each mouse because the spectroscopic 
T1 measurement requires considerable prolongation of measuring time. However, the 
described method will be of essential importance for quantification of metabolites in 





The intra-individual reproducibility study was carried out by acquiring six spectra 
from the medial cortex region (MCX) of an animal under similar experimental conditions, 
in three different sessions, spaced several months apart. For the inter-individual study, 
data was obtained from 9 animals and each, of which, was measured only once. In order 
to minimize variability, due to voxel positioning, an oblique VOI of 6.75 μL was carefully 
placed in MCX by a single investigator during all the scans. As previously mentioned, a 
stereotaxic holder, incorporated in a home-built animal slider, was used to appropriately 
immobilize the head of the anaesthetized mice. The coefficient of variation (CV) (given 
as %CV = (SD/M) × 100 where M and SD are the mean and standard deviation of the 
metabolite concentration reported by LCModel) was determined to characterize intra- 










4.3 Results  
Regional Differences 
High-quality multi-slice RARE images of the mouse brain ensured accurate and 
reproducible positioning of the VOI in different brain regions. Representative water-
suppressed in vivo proton MR spectra of the investigated mouse brain regions clearly 
show the well-resolved resonances of numerous cerebral metabolites signals (see Fig. 
4.4), obtained with sufficiently consistent spectral quality, e.g., SNR and linewidth, Table 
4.5.  
The spectra include resonances from Ala, Asp, Cr, PCr, GABA, Glu, Gln, Cho, Ins, 
Lac, NAA, NAAG and Tau. Considerable spectral variations among the various 
investigated brain regions can be observed. 
  
     




Figure 4.4: Localized proton MR spectra (STEAM, TR/TE/TM=6000/10/10 ms, 4.2 to 15.5 μl VOIs, 2 × 128 
accumulations per animal) from selected locations in normal mouse brain obtained in vivo at 9.4 T. For 
illustration purposes only, spectral post-processing comprised of zero-filling to 4K data points, mild 
Lorentz–Gauss apodization in the time-domain (half width 88 msec, corresponding to 5 Hz line 
broadening) and phase correction according to LCModel. Spectra were scaled in absolute units in 
proportion to the brain water concentration.   
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The LCModel analysis of a typical proton MR spectra from the thalamus of a 
NMRI mouse brain are presented in Figure 4.5 to illustrate the principle of employed 
fitting method in the frequency domain. The fitted spectrum is decomposed into its 
component model spectra from individual brain metabolites, which are individually 
scaled. The fitting residual, i.e. the difference between the measured and fitted spectra, 
is small, flat and artifact-free, which is a clear indication of the excellent fit by LCModel, 
achieved through a proper inclusion of metabolites model spectrum in the basis set. Flat 
macromolecular ‘‘baseline” estimated by LCModel, specifically in the spectral region 
from 0.5 to 2.0 ppm, is an indication of its successful simulation of fast-relaxing signals 
from macromolecule. 
Furthermore, the C4 proton resonances of Glu (2.35 ppm) were completely 
resolved from those of Gln (2.45 ppm). Additionally, the GABA C4 resonance at 2.28 ppm 
was discernible from the resonance of Glu C4. And its C3 quintet, centered at 1.89 ppm, 
was clearly discriminated from the signal of NAA. The latter was most notably observed 
in the thalamus and striatum, where GABA concentrations are maximally, and it was 
least notably detected in other regions where GABA was hardly visible.  
 
     




Figure 4.5: LCModel fit of a representative proton MR spectrum from the thalamus of the mouse brain in 
vivo at 9.4 T obtained with use of a short-echo time STEAM sequence (see Fig. 3.5). From the top: 
residuals, in vivo spectrum, fitted spectrum, macromolecules, and spectral contributions of individual 
metabolites to the total spectral fit. All spectra are scaled consistently. See text for abbreviations.  
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Basic spectral parameters, determined by LCModel, were compared in Table 4.4 
to demonstrate detailed regional differences in the achieved spectral quality so that its 
impact on reliability of the concentration estimates could be evaluated. Mean 
metabolite linewidths, determined from full linewidth at half maximum (FWHM) of total 
creatine singlet at 3.03 ppm, reflect the results of localized shimming using FASTMAP. 
Signal-to-noise ratios (SNRs) were calculated in frequency domain, using the 
maximum height of signal at the position of NAA methyl resonance at 2.008 ppm, 
divided by the root mean square (rms) of the residues. Mean linewidths vary across the 
investigated regions, however this observation was independent of the VOIs size and 
mainly depended on VOI locations and dimension. First of all, tissue heterogeneities 
within selected VOIs can cause line broadening. For example, the VOI of 170 x 700 x 
4000 μm3 was selected for the corpus callosum, which ensures a reasonable covering of 
the structure, while providing sufficient SNR within a limited measuring time. However, 
the actual volume of white matter in this VOI is much smaller. This means that different 
types of tissue (e.g., cell body assemblies, neuropils), other than the white matter, are 
included in the VOI, which may lead to magnetic field heterogeneities due to 
susceptibility differences. The placement of VOI within pure white matter is excluded, 
because the dimension of pure white matter can be estimated to be 250 × 100 × 500 
μm3 (Michaelis et al., 2009). The selection of such small VOI attenuates the SNR by a 
factor of 38 and therefore causes unrealistic measuring time. Further, increased FWHM 
in corpus callosum, callosal fibres and cerebellum can be partly explained by the need 
for positioning larger cubical volume of FASTMAP which encompassed the other 
undesired brain region rather than the selected VOI itself. Apart from that, localized 
shimming is impaired in BS, due to the fact that it is located further away from the 
surface coil. The resulting lower SNR deteriorates the shimming performance of 
FASTMAP. 
As described in the methods, the mean CRLBs of LCModel analysis across all 
metabolites were utilized to assess the reliability of metabolite quantification. The mean 
of the estimates of fitting error expressed in % are consistent with those expressed in 
units of concentration (mmol/liter VOI). As expected, it is noticed that the precision of 
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metabolite quantification slightly degraded [deteriorated] in the location with the lower 
SNRs and larger linewidths, e.g., in the callosal fibers and brainstem. 
 
Table 4.4. Comparison of metabolite linewidths and SNR of spectra together with CRLB 
determined using LCModel from different mouse brain region to characterize the 
achieved spectral quality and the reliability of metabolite quantification. 
           Structure 
 
      
 
mcx lcx cc cf st mth lth hc cb bs 
  n=8 n=7 n=9 n=8 n=8 n=9 n=9 n=9 n=8 n=5 
Volume (μl) 6.8 5.6 4.8 4.2 11.0 15.5 9.2 4.6 6.1 8.3 
SNR 14.1 12.4 8.6 7.7 13.9 18.4 11.7 9.4 11.9 7.8 
FWHM (Hz) 8.8 10.4 12.4 11.6 9.6 8.0 8.4 7.2 9.6 12.0 
CRLB (%) 9.8 10.2 12 12.7 9.9 9.3 11.3 12 13.6 15.5 
CRLB (mM) 0.29 0.3 0.4 0.43 0.3 0.27 0.34 0.4 0.45 0.51 
mcx = medial cortex, lcx = lateral cortex, cc = corpus callosum, cf = callosal fibres, st = striatum, mth = medial 
thalamus, lth = lateral thalamus, hc = hippocampus, cb = cerebellum, bs = brainstem 
 
Absolute concentrations (mean ± SD) of 16 metabolites were reliably quantified 
in different brain regions, which were obtained by the LCModel analysis of all acquired 
in vivo 1H NMR spectra (NT = 256) from nine animals measured at 9.4 T. Results of 
quantitative evaluation of metabolites, along with four combined pairs of metabolites, 
are illustrated in Figure 4.6. 
The corresponding average Cramer–Rao lower bounds (CRLB), which are the 
approximations of fitting errors and uncertainties of metabolite concentrations, were 
below 20% for most of the metabolites, for all regions. 
Total NAA, i.e., N-acetylaspartate and N-acetylaspartylglutamate (tNAA, NAA + 
NAAG), total creatine, i.e., creatine and phosphocreatine (tCr, Cr + PCr), total choline, 
i.e., glycerophosphocholine and phosphocholine (tCho, GPC + PCh), combined glutamate 
and glutamine (Glx, Glu + Gln), taurine (Tau), NAA, Cr, Glu and lactate (Lac) were 
quantified with average CRLB < 8 %. 
For some weakly represented metabolites, CRLB was greater than 20% in some 
brain regions. The CRLB was between 6 % and 40% for alanine (Ala), while it was in the 
range of 15–30% for NAAG. However, γ-aminobutyric acid (GABA) concentration was 
measured with the estimate of fitting error ranging from 5 to 15 %. Aspartate and 
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glucose were only detected (CRLB < 50%) in three and four animals for the striatum, 
respectively. 
In spite of the fact that scyllo-Ins signal was incorporated into the basis set of 
LCModel as a model component, corresponding concentration was only possible to 
quantify in the medial thalamus (0.19 ± 0.01 mM, N = 3); thus, this metabolite was not 
further evaluated and it was disregarded from the bar diagram in Figure 4.6. 
  
     






  Figure 4.6: Cerebral metabolite concentrations (in mM per liter VOI) determined by LCModel analysis of 
the in vivo 
1
H NMR spectra of ten different regions in brain of mice. Error bars indicate standard 
deviations. mcx = medial cortex, lcx = lateral cortex, cc = corpus callosum, cf = callosal fibres, st = striatum, 
mth = medial thalamus, lth = lateral thalamus, hc = hippocampus, cb = cerebellum, bs = brainstem. 
  
     







  Figure 4.6: Continued.   
     




 Figure 4.6: Continued. 
 
 
More detailed information on absolute metabolite concentration estimates, 
along with corresponding Crame´r-Rao lower bounds of LCModel, are given in Table 4.5.  
  
     















































































































































































































































































































































































































































































































































































































































































































































































































































































     




















































































































































































































































































































































































































































































































































































































































































































































































































































     




Figure 4.7 shows spectra obtained from the same VOI in the medial cortex region of an 
individual animal on three different occasions. The bottom trace represents the spectra 
from back-to-back measurements on each session. The spectral quality was highly 
reproducible, as indicated by the resemblance among all the spectra.  
 
 
Figure 4.7: Representative in vivo 
1
H NMR spectra from 6.75 μL volume in the medial cortex of an 
individual animal from three different sessions (top trace) and their corresponding spectra from back-to-
back measurements (bottom trace). Acquisition and processing parameters as well as peak assignments 
are the same as in Fig. 4.4.  
 
The intra- and inter-individual variability of metabolite concentrations as well as the 
respective mean CRLB values are summarized in Table 4.6 for medial cortex.  
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Table 4.6 Absolute metabolite concentrations (mean ± SD), the coefficients of 
variation (CV) and Crame´r–Rao lower bounds (CRLB) from the intra- and inter-
individual studies, obtained by LCModel analysis of in vivo NMR spectra from medial 
cortex region of the healthy mouse brain. 
 
                    intra (n = 6)                      inter (n = 9) 
Metabolite  Mean ± SD CV CRLB  Mean ± SD CV CRLB 
  (mM) (%) (%)  (mM) (%) (%) 
Ala  1.17 ± 0.43 37 29  1.07 ± 0.39 36 29 
GABA  2.24 ± 0.30 13 12  2.10 ± 0.26 12 12 
Glc  3.99 ± 1.22 31 18  3.72 ± 1.79 48 20 
Tau  7.67 ± 0.43 6 4  8.24 ± 0.68 8 4 
NAA  7.45 ± 0.44 6 4  7.46 ± 0.57 8 3 
NAAG  0.94 ± 0.26 28 26  0.95 ± 0.22 23 24 
Cr  6.50 ± 0.70 11 7  6.25 ± 1.16 19 8 
PCr  2.11 ± 0.49 23 22  2.37 ± 0.70 30 19 
Gln  4.40 ± 0.32 7 9  3.60 ± 0.35 10 11 
Glu  10.93 ± 0.63 6 4  11.61± 0.96 8 4 
GPC  0.95 ± 0.10 11 10  0.83 ± 0.13 16 11 
PCh  1.19 ± 0.11 9 8  1.26 ± 0.19 15 7 
Ins  2.78 ± 0.43 15 11  2.79 ± 0.21 8 10 
Lac  3.27 ± 0.92 28 9  3.13 ± 0.72 23 9 
Asp  1.92 ± 0.31 16 29  2.00 ± 0.59 30 29 
NAA+NAAG  8.38 ± 0.40 5 4  8.41 ± 0.61 7 4 
Cr+PCr  8.60 ± 0.35 4 3  8.62 ± 0.55 6 3 
GPC+PCh  2.14 ± 0.20 9 5  2.09 ± 0.29 14 5 
Glu+Gln  15.33 ± 0.54 4 4  15.21 ± 0.90 6 4 
 
The intra-individual coefficient of variation (CV) for most metabolites (NAA, Cr, 
Glu, Gln, Tau, GPC, PCh, tCr, tCho, tNAA, Glu+Gln) was ≤ 11% and was below 15% for 
GABA and myo-Ins. Additionally, this value ranged from 16% to 37% for weakly 
represented metabolites (Asp, NAAG, Ala). These are in agreement with results of the 
rat brain, reported by Pfeuffer and Hong at field strengths of 9.4 T and 16.4 T, 
respectively (Pfeuffer et al., 1999, Hong et al., 2011b). The inter-individual CV was found 
to be rather similar to that observed in the study of intra-individual variability.  
The lower CV of the summed metabolites indicates that the resonances of the 
related individual components are obscured by spectral overlap and hence, were only 
partially resolved. This is further characterized by decreased mean CRLB (estimate of the 
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fitting error) for the summed metabolites, compared to their individual values in both 
intra- and inter-individual reproducibility studies, as can be seen in Table 4.2.  
The CRLBs estimated by LCModel were consistent with the CVs values, measured 
for each metabolite concentration. The mean CRLB values for all metabolites were 
nearly identical in intra- and inter-individual studies, representing the reliability and 
robustness of the LCModel fitting analysis, from a single spectra, to quantify the 





Care was taken to optimize dimension of VOIs for every region to ensure better 
localization and to include maximum area of the brain structure. This leads to 
diminished partial volume effects and avoids ventricular space contribution, within the 
selected volume. However, the remnant uncompensated susceptibility results in 
inhomogeneous line broadening and in deterioration of the achievable spectral 
linewidths, which are markedly noticeable in locations with strong susceptibility 
gradients.  This may be caused by air–tissue interfaces in inferior regions of the brain or 
it may be induced by paramagnetic properties of blood, close to the vessels. This 
influence is manifested as a distortion in magnetic field homogeneity which thus, limits 
spectral resolution and increases resonance linewidths from 7.2 ± 1.6 Hz for tCr obtained 
in hippocampus to 12.0 ± 1.6 Hz and 12.4 ± 1.6 Hz attained in brainstem and corpus 
callosum, respectively (see Table 4.4). As far as the optimization of the hardware is 
concerned, the replacement of the standard 1 kW RF power amplifier by that of 2 kW 
allowed shortening of the slice-selection RF pulse duration, which greatly reduced the 
extent of the chemical shift displacement error to below 10% of the voxel dimension. 
The high spectral quality achieved over the entire chemical shift range (0.5–4.2 
ppm) ensured reliable and reproducible quantification of each of the brain metabolites. 
Signals of many metabolites were clearly resolved as a consequence of increased 
chemical shift dispersion at 9.4 T. For example, this is reflected in the complete 
separation of the coupled resonances of Tau from myo-inositol resonances at 3.42 ppm. 
Furthermore, the C4 proton resonances of Glu (2.35 ppm) were completely resolved 
from those of Gln (2.45 ppm). Additionally, the GABA C4 resonance at 2.28 ppm was 
discernible from the resonance of Glu C4. And its C3 quintet centered at 1.89 ppm was 
clearly discriminated from the signal of NAA, notably in the thalamus and striatum 
where the maximum GABA concentration observed and hardly visible in other 
structures. 
Furthermore, the singlet resonances from methylene-protons of creatine and 
phosphocreatine, differing by 0.02 ppm, were partially resolved at 3.9 ppm (Gruetter et 
al., 1998, Pfeuffer et al., 1999, Tkád et al., 2003) and they were discernible in the 1H NMR 
spectra, obtained from most of the brain regions. Here, it may be worth noting that the 
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strong negative correlation between Cr and PCr, as estimated from the covariance 
matrix by the LCModel, would imply a decrease in reliability of individual quantification. 
In fact, this can give rise to overestimation of one constituent concentration, to the 
detriment of underestimation of the other (Hofmann et al., 2002, Tkád et al., 2009). 
However, the sum of Cr and PCr concentration were quantified with high precision. The 
measured concentrations of tCr in the current study are in good agreement with 
previously published concentration values for normal mouse (Renema et al., 2003, 
Schwarcz et al., 2003, Öz et al., 2010) and rat brain in vivo (Pfeuffer et al., 1999, Tkád et 
al., 1999, Hong et al., 2011a, Hong et al., 2011b, Hong et al., 2011c). Similar arguments 
hold true for signal from tCho at 3.2 ppm, which comprises resonances predominantly 
from the trimethyl amine N-(CH3)3 groups of GPC and PC, although an even stronger 
LCModel correlation coefficient of <-0.85 may lead to large uncertainties in 
measurement of the individual constituent. 
In addition to notable reductions in scan time, increased sensitivity and spectral 
resolution at 9.4 T, compared to those at 2.35 T, resulted in a substantial improvement 
in accuracy and precision of the quantification of metabolites - particularly for those 
weakly represented. The higher CRLB observed for metabolites with J-coupled spin 
systems, compared to uncoupled ones, can be explained by the pronounced splitting of 
their resonances, which considerably overlap with those of more abundant metabolites. 
A plausible explanation emerges from the analytical expressions of the CRLBs on spectral 
parameters, as derived by Cavassila, demonstrating the influence of overlap on the 
model parameter estimates (Cavassila et al., 2000, Cavassila et al., 2001, Cavassila et al., 
2002, Kreis, 2004). In this context, it is important to note that the larger standard 
deviations in metabolite concentration values, obtained in e.g., the brainstem and 
corpus callosum, can be attributed to systematic errors introduced by reduced SNR and 
increased line width (see Table 4.4 and Fig. 4.6). Indeed, overestimation of weakly 
represented metabolites as a function of SNR has been reported by Tkád et al (Tkád et 
al., 2002). Influences of linewidth and SNR on estimated metabolites concentration have 
also been shown (Kreis and Boesch, 2003, Bartha, 2007).  
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The observed regional differences of metabolite concentrations in vivo are in line 
with literature data, except for tCho (choline-containing compounds, i.e., GPC + PC), Lac, 
and Ala. The observation of elevated tCho concentrations in the striatum, reported here 
for the first time, was highly reproducible and consistent among animals, while the 
concentration of about 2.0 mM in the hippocampus, thalamus, and medial cortex is 
higher than expected from a previous report (Tkád et al., 2004). These discrepancies may 
be explained by the difference in the strain of mice used (NMRI in the present report vs. 
C57BL/6, CBA, and CBA/BL6 in the previous report).  
The observation of the pronounced differences in Lac and Ala content, among 
various brain regions, generally agree with those reported by others in rats (Tkád et al., 
2003) and mice (Tkád et al., 2004, Boretius et al., 2011) at 9.4 T. A new finding of the 
present study, however, was markedly higher (37 %) Lac concentration of brainstem, 
compared to striatum (see Fig. 4.6). These novel findings may be related to the mouse 
strain used and may also depend on the procedures used for anesthesia. Indeed, the 
experimental setup which has been established within the frame of this thesis recently 
provided data, which partially explains the altered cerebral metabolism, under the 
applied anesthesia (Boretius et al., 2013). The observed alterations can be explained by 
the effect of used volatile anesthetic, i.e., isoflurane, which may induce a stimulation of 
adrenergic pathways, in conjunction with an inhibition of the respiratory chain. The 
higher Lac concentration in the brainstem suggests that the brainstem may be more 
vulnerable to the induced physiological conditions, possibly because of its high content 
of adrenergic neurons. 
Scyllo-Ins, a potential marker for human cerebral pathology, has been supposed 
to have a constant concentration, relative to myo-ins. In The concentration of scyllo-Ins 
was reported to be 0.4-0.6 mM in human brain (Seaquist and Gruetter, 1998), while that 
of myo-ins is approximated to be about 6 mM (Michaelis et al., 1993a). In the present 
study, the concentration of scyllo-Ins cannot be quantified with sufficient reliability, 
except from the medial thalamus (0.19 ± 0.01 mM) and the detected concentration of 
myo-ins, ranging between 1.82 and 6.37 mM, is in line with previously reported data of 
both humans and mice  (Tkád et al., 2004). This lack of reliable detection in most regions 
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of the brain, presumably due to its low concentration, can be explained by the 
assumption of Seaquist and Gruetter that scyllo-Ins metabolism may be regulated 
independently from myo-ins. 
The high reproducibility and reliability of the presented quantitative, single-voxel 
proton MRS measurements in the mice brain at 9.4 T, as emphasized by the small CV 
and CRLB in Table 4.6, correspond well with previous data (Öz et al., 2010) and hold 
great promise for the ability to reliably detect subtle changes in metabolite 
concentration - for example, those associated with the progression of 
neurodegenerative diseases or therapeutic response to pharmacotherapy. The excellent 
agreement observed between the CRLB values returned by LCModel and the calculated 
CV values (see Table 4.6), which were measured for each metabolite concentration, 
confirms the good quality of the obtained data and the subsequent successful 
approximation by the model functions. 
 The lower value for CRLB was considered to stem from the fact that it represents 
the lower bound on the variance of unbiased estimate of the model parameter in the 
presence of normally distributed noise and reflects only the statistical uncertainty of the 
estimate; therefore, the larger scatter (e.g., standard deviation) in the observed data 
(Table. 4.5 and 4.6) can be explained by the systematic errors, e.g., incorrect prior 
knowledge and numerous artifacts (Provencher, 1993, Kreis, 1997, Cavassila et al., 2000, 











Summary and Outlook 
 
 
 The first achievement of this work was implementation and optimization of MRS 
technique. To achieve this goal, (i) MR spectra, acquired with different bandwidths and 
inter-pulse delays of water suppression pulses, were systematically investigated for in 
vitro condition as well as for mouse brain in vivo. Sufficient water suppression allowed a 
reliable detection of critical metabolite signals, despite their close proximity to the water 
resonance. Minimum spoiling capacity chosen ensured a sufficient dispersion of 
transverse water coherences. (ii) The implemented outer-volume-suppression scheme 
allowed substantial improvement in quantification of metabolites in mouse brain. (iii) 
The improvement in local static field homogeneity, achieved by FASTMAP shimming, 
resulted in high and reproducible spectral resolution. (iv) The relative detectability of 
strongly coupled metabolite resonances was systematically compared between low and 
high field strengths, using a single phantom and mice of matching strain, gender, and 
age. 
 The second achievement was the acquisition of MR spectra and representation 
of the neurochemical profiles from ten different brain regions of anesthetized mice at 
9.4 T. Experimental setup was developed, including the selection of the coils, the 
method of anesthesia, the maintenance of body temperature, and the fixation of the 
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head of mice for repeated MRS from the same mouse and for examining the 
reproducibility of MRS. VOI localization technique was optimized for different brain 
regions of anesthetized mice. Measurement of T1 and T2 relaxation times from different 
brain regions of anesthetized mice may be used for a correct quantification of 
metabolite concentrations in order to calculate the partial volume effect of the 
cerebrospinal fluid, the signal attenuation difference between the tissue in vivo and the 
metabolite model solution in vitro, and the water content of the tissue in vivo. Absolute 
concentrations of 15 different brain metabolites from anesthetized mice were presented 
with their necessary statistical values. Elevated tCho and Ala concentrations in the 
striatum as well as elevated Lac concentration in the brainstem, so far not reported, 
were firstly demonstrated. Scyllo-Ins signal was quantified, for the first time, from the 
brain of mice in vivo. High reproducibility of MRS was demonstrated from the same 
mouse over four months.  
A further reduction in chemical shift displacement error remains an issue, 
although it was reduced to below 10% of the voxel dimension by the application of 
optimal RF power amplifier, together with the shortening of the slice-selective RF pulse, 
in the present work. An optimal use of adiabatic slice selective RF pulses, e.g., hyperbolic 
secant pulses, may provide even larger bandwidth, which thus minimizes the chemical 
shift displacement error. 
Further improvement in spectral resolution may be achieved by a phase coherent 
averaging. Development of an interleaved navigator scan may counteract motion 
artifacts and magnetic field instabilities. Consequently, SNR improvement is also 
expected. The signal-to-noise gain may be further expected, when full advantage is 
taken of phased-array coil (Natt et al., 2005) or of cryo-probe. Further, the basic 
knowledge acquired here, from comparison between 2.35 T and 9.4 T, will be useful for 
optimization of MRS at even higher fields.  
For the quantification of metabolites, an assumed value of water content was 
used for all regions because the spectroscopic T1 measurement requires considerable 
measuring time. A faster imaging technique for spin density mapping may be developed 
to derive water content of each region. This will be of great importance when 
characterization of pathology with altered water content is required. Furthermore, 
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metabolite-nulled spectra can be acquired in vivo (Pfeuffer et al., 1999, Auer et al., 2001, 
Seeger et al., 2003) and included into the basis set of LCModel, signals from 
macromolecules can be quantified. 
 In summary, High-field localized proton NMR spectroscopy, accompanied by 
LCModel analysis, enabled detection of regional differences in the neurochemical 
profiles of the normal mouse brain in vivo. This allows detailed studies of metabolic 
heterogeneity to be conducted in a region-specific manner that hitherto could only have 
been made on larger animals such as rats and nonhuman primates. The data yield 
unique non-invasive insights into the intracellular metabolism and the cellular 
composition of the tissue. The comprehensive data of absolute metabolite 
concentration presented in this thesis will serve as a reference for all future MRS 
studies, using behaving mice in a variety of circumstances. Pertinent studies may lead to 
a better understanding of the pathophysiological mechanisms underlying human 
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